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ABSTRACT 
 
JON RUSSELL SOBUS: Comparing Urinary Biomarkers of Exposure to Polycyclic 
Aromatic Hydrocarbons 
(Under the direction of Stephen M. Rappaport) 
 
Polycyclic aromatic hydrocarbons (PAHs), which consist of two or more fused aromatic 
rings, are ubiquitous products of combustion.  These compounds are found in wood and 
tobacco smoke, engine (particularly diesel) exhausts, and in numerous workplaces, including 
those producing coke and aluminum and those processing hot asphalt.  Because some PAHs 
are potent carcinogens, it is important to assess the levels of exposure to these compounds 
that are received by workers and the general public.  However, PAHs are difficult to measure 
in the environment because they exist in both the gas phase and the particulate phase, and the 
carcinogenic particle-bound compounds are present at very low concentrations.  In contrast, 
the smaller vapor-phase PAHs are more abundant in the environment and produce a host of 
urinary products that can be used as biomarkers of exposure.  Here we consider the 
hypothesis that urinary biomarkers of naphthalene (a 2-ring compound) and phenanthrene (a 
3-ring compound) can be used as measures of exposure to total PAHs.  We test this 
hypothesis in three distinct phases of research.  First, we determine the predictive value of 
airborne naphthalene and phenanthrene as measures of exposure to diesel exhaust in a 
controlled chamber study.  Second, we determine the predictive value of urinary levels of 
naphthalene and phenanthrene as measures of occupational exposure to diesel exhaust, 
asphalt emissions, and coke-oven emissions.  And finally, we develop statistical models of 
 ii
urinary biomarkers of naphthalene and phenanthrene in asphalt-exposed workers to 
determine effects of particulate PAH levels in air and on the skin, job categories and tasks, 
and physiological factors that might affect the uptake and elimination of these compounds.  
Overall, this research demonstrates that urinary biomarkers of naphthalene and phenanthrene 
can be used as measures of exposure to total PAHs in air and on the skin.   
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1. Background and Significance 
 
1.1. PAHs 
 
1.1.1.  Occurrence and health effects  
 
Polycyclic aromatic hydrocarbons (PAH) are a large class of chemicals composed of 
two or more fused aromatic rings.  These chemicals are formed by the incomplete 
combustion of organic materials, and are therefore ubiquitous contaminants of the world’s 
air, water, and soil.  Sources of PAHs from the natural environment include forest fires and 
volcanoes; occupational PAH sources include coal tar, coal tar pitch, coke tars, coke-oven 
emissions, creosote, asphalt (also known as bitumen), and industrial smoke and soot; 
additional anthropogenic sources include motor vehicle exhaust derived from diesel-powered 
engines, tobacco smoke, and char-broiled foods.  Considering the breadth and variety of 
environmental sources, human exposures to PAHs occur though inhalation of polluted air, 
ingestion of contaminated food and water, and dermal contact with PAH-containing 
products. 
Although hundreds of individual PAHs have been identified (NIST 1997), the 
assessment of exposures to PAHs is often based on a subset of commonly occurring 
consitituent compounds (ATSDR 1995), including acenaphthene (Ace), acenaphthylene 
(Anap), anthracene (Ant), benz(a)anthracene (BaA), benzo(a)pyrene (BaP), benzo(e)pyrene 
(BeP), benzo(b)fluoranthene (BbF), benzo(g,h,i)perylene (BgP), benzo(b)fluoranthene (BbF), 
benzo(k)fluoranthene (BkF), chrysene (Chr), dibenz(a,h)anthracene (DaA), fluoranthene 
(Fla), fluorene (Flu), indeno(1,2,3-c,d)pyrene (Ind), naphthalene (Nap), phenanthrene (Phe), 
and pyrene (Pyr).  Of this group, only Nap, a 2-ring PAH, exists almost entirely in the 
gaseous phase.  The 3-ring PAHs (e.g., Phe) exist both in gaseous and particulate forms, and 
the larger compounds with 4 or more rings (e.g., BaP) typically exist adsorbed to particulate 
matter.   
 Chronic exposure to PAHs in some work environments has been associated with 
human cancers, specifically those of the lung, skin, and bladder (Boffetta et al. 1997). 
Although studies have linked Nap with lung tumors in rats and mice (Abdo 1992; NTP 1992; 
NTP 2000; Abdo et al. 2001), the larger 4-6 ring PAHs (Chr, BaA, BbF, BkF, BaP, DaA, 
Ind, and BgP) appear to posses the greatest carcinogenic potency (IARC 1983; IARC 1987).  
Of these 4-6 ring compounds, BaP is a known human carcinogen (IARC Vol. 92 in 
preparation) is used as an index of the health hazards associated with PAH exposure (EPA 
1993).    
Noncancer health effects of PAH exposure include decreased ventilatory function (as 
evidenced by breathing problems, bloody vomit, chest pains and irritation, and pleural 
effusions) and reduced serum immunoglobulins (specifically serum IgG and IgA) (ATSDR 
1995).  Recent studies have identified an association between adverse reproductive outcomes 
and exposures to PAHs during pregnancy.  Specifically, studies have shown that elevated 
exposure to PAHs can result in reduced fetal growth, birth weight, gestational duration, and 
head circumference (Dejmek et al. 2000; Lederman et al. 2004; Perera et al. 2005b).  Also, it 
is suggested that a developing fetus has increased susceptibility to DNA damage from PAH 
exposure, perhaps leading to a disproportionate cancer risk (Perera et al. 2005a). 
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1.1.2.  Metabolism of PAHs 
PAHs are lipophilic compounds that can penetrate cellular membranes and be stored 
in adipose tissue.  Metabolic transformation via Phase-I and Phase-II enzymatic activity 
renders PAHs more water soluble and suitable for excretion.  While the metabolism of PAHs 
has been studied both in vitro (cultured human cells) and in vivo in several species of animals 
(ATSDR 1995), little data exist as to the in vivo metabolism of PAHs in humans.  Despite 
these data gaps, it is thought that the structural similarities in many PAH compounds lead to 
similarities in their metabolism (ATSDR 1995).  As BaP is used to gauge the relative toxicity 
of other PAHs, it is also frequently used to model PAH metabolism.  As shown in Figure 
1.1., BaP is first oxidized by cytochrome P-450 (1A1, 1A2, 1B1, 3A4, 2C), forming several 
PAH epoxides (Daly et al. 1972; Bauer et al. 1995).  It is hypothesized that phenols may also 
be formed from the parent compound in the liver by direct oxygen insertion (Gelboin 1980; 
Levin et al. 1982).  PAH epoxides can: 1) spontaneously rearrange to phenols, which are then 
either oxidized to form quinones, or conjugated (via UGT1A6 or SULT1A1) and excreted in 
the urine, 2) react covalently with glutathione as catalyzed by glutathione-S-transferases 
(GSTM1, GSTT1, GSTP1), 3) react with macromolecules to form adducts (Viau and Carrier 
1995; Boysen and Hecht 2003; Brandt and Watson 2003), or 4) undergo hydration to the 
corresponding trans-dihydrodiols via microsomal epoxide hydrolase (Boyland and Levi 
1935; Booth and Boyland 1949).  Dihydrodiols can be: 1) eliminated in the urine (either free 
or conjugated via UGT2B7), 2) converted to catechols (via dihydrodiol dehydrogenase), 
which are then either oxidized to ortho-quinones (Smithgall et al. 1986; Smithgall et al. 
1988; Flowers-Geary et al. 1995) or conjugated and eliminated in the urine, or 3) oxidized 
(via cytochrome P-450 1A1, 1A2, 1B1, 3A4, 2C) to diolepoxides (Sims et al. 1974; Kim et 
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al. 1998).  Diolepoxides can be: conjugated with glutathione (GSTM1, GSTT1 or GSTP1), 
hydrolyzed to tetraols via epoxide hydrolase (Simpson et al. 2000), or form macromolecular 
adducts with either protein, RNA, or DNA (Koreeda et al. 1978; Szeliga and Dipple 1998; 
Dipple et al. 1999).  Bay-region diolepoxides (e.g., the 7,8-dihydrodiol-9,10-epoxide of BaP) 
are recognized as promutagenic tumorigenic metabolites of several PAHs (ATSDR 1995).  In 
addition, ortho-quinones formed during the metabolic process are known to undergo redox 
cycling, thereby forming reactive oxygen species (ROS), such as the superoxide anion, 
hydrogen peroxide, and hydroxyl radicals.  These ROS can cause oxidative stress within 
cells, thus damaging cellular macromolecules and activating signaling pathways (Bolton et 
al. 2000).  Therefore, production of ortho-quinones in PAH metabolism offers a mechanism 
of carcinogenesis other than the production of promutagenic DNA adducts by PAH 
metabolites. 
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Figure 1.1. Proposed metabolic scheme for PAHs using BaP as a prototype 
[adopted from (ATSDR 1995)]. 
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1.1.3. PAH exposure assessment 
Beginning in 1775, when Sir Percival Pott recognized an increased incidence of 
scrotal cancer in chimney sweeps (Pott 1775), causal associations have been made between 
occupational exposures to PAHs and human cancers, notably in the production of steel, iron, 
and aluminum, where exposure levels are very high (Boffetta et al. 1997).  However, in work 
environments containing low to moderate levels of PAHs, (e.g., those involving exposure to 
diesel exhaust and asphalt emissions), causal associations between PAH exposure and cancer 
incidence are more uncertain (NIOSH 2000; EPA 2002).  This uncertainty stems, in part, 
from the general lack of quantitative data regarding levels of PAH exposures in these 
workplaces.   
In a typical workplace, volatile and semivolatile PAHs (i.e., 2- and 3- ring PAHs) are 
more abundant than those bound to particulate matter (Bjorseth and Lunde 1977; Bjorseth et 
al. 1978a; Petry et al. 1996; Kuusimaki et al. 2002; Strunk et al. 2002; Kuusimaki et al. 2003; 
Rappaport et al. 2004).  Nontheless, most assessments of exposures to PAHs focus upon the 
particulate fraction because the 4-6 ring compounds tend to be more potent carcinogens.  
These measurements of airborne particulate matter require cumbersome and expensive 
sampling equipment, such as battery-operated pumps that are worn by study participants.  
While volatile and semivolatile PAHs are not as strongly associated with health effects, their 
relatively large abundance allows them to be quantified more easily in air.  In fact, since 
smaller 2- and 3- ring PAHs (e.g., Nap and Phe, respectively) are often observed primarily in 
the gas phase, air concentrations can be measured using passive sampling techniques that do 
not require portable pumps (Egeghy et al. 2003).  These more affordable sampling techniques 
increase the ability to obtain more air measurements at a given cost for studies of health 
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effects (Rappaport 1991).  Since air levels of Nap have been shown to be highly correlated 
with those of total measured PAHs in studies of workers in the steel and aluminum 
industries, the use of Nap and Phe as surrogates for exposures to all PAHs (hereafter ‘total 
PAHs’) is an appealing possibility (Rappaport et al. 2004).   
 
 
1.1.4. Biomarkers of PAH exposure 
Given potential contributions to total PAH exposure from inhalation, ingestion, and 
dermal contact, and the use of personal protective equipment (primarily respirators and 
gloves), there is a need for good biomarkers of PAH exposure.  A biomarker of exposure is 
generally considered to be either the parent compound or its metabolic product(s) in exhaled 
breath or a bodily fluid (NRC 1987).  Biomarkers of effect, on the other hand, include 
measures of DNA or tissue damage, including DNA adducts, mutagenicity, chromosome 
damage, etc.  In fact, the first biomarkers applied to PAH-exposed subjects were based on 
mutagenic activity in urine samples (Moller and Dybing 1980; Recio et al. 1984; Venier et al. 
1985).  These methods lacked the sensitivity and specificity to attribute mutagenic activity to 
exposures to particular PAHs, and thus, had limited applications.   
A more useful biomarker of PAH exposure involves measurement of 1-
hydroxypyrene (OH-Pyr) in urine (Keimig et al. 1983; Jongeneelen et al. 1985; Jongeneelen 
et al. 1987).  While other Pyr metabolites have been described (Harper 1957; Boyland and 
Sims 1964; Jacob et al. 1982), OH-Pyr is the main urinary metabolite of Pyr.  Studies in 
many different working environments have linked OH-Pyr levels to PAH exposure [reviewed 
in (Jacob and Seidel 2002; Hansen et al. 2008)].  While Pyr, a 4-ring PAH, is a useful 
surrogate for particle-bound PAHs, certain disadvantages are associated with using OH-Pyr 
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more generally as a biomarker of total PAH exposure.  Since only one metabolite of Pyr is 
measured in the urine, little insight is gained regarding variability in PAH metabolism as a 
function of exposure and the influence of covariates such as gender, race, age, and genetic 
factors.  In addition, Pyr is not carcinogenic (IARC 1983; IARC 1987), nor does it produce a 
bay-region diolepoxide via biotransformation, a feature closely associated with the 
tumorigenic potential of PAHs (ATSDR 1995).   
To more accurately assess exposures to carcinogenic PAHs and their subsequent 
metabolism, BaP metabolites have been investigated as biomarkers of PAH exposure.  
However, this strategy is problematic due to the very low levels of BaP metabolites in urine 
from all but the most highly exposed workers, and the fact that BaP metabolites are 
predominantly excreted in the feces rather than the urine [reviewed in (Jacob and Seidel 
2002)]. 
Taking into consideration their high relative abundance, several smaller PAHs have 
recently been considered as biomarkers of PAH exposure.  Although Nap does not produce a 
bay-region diolepoxide, it is metabolized and excreted as phenolic and dihydrodiol 
conjugates in human urine (Serdar et al. 2003b; Serdar et al. 2004; Wu et al. 2005).  
Additionally, protein adducts of the naphthoquinones (metabolites of Nap) have been 
measured in human serum albumin (Waidyanatha et al. 2004).  The availability of these 
biomarkers of exposure, coupled with the ability of Nap to cause respiratory tumors in 
rodents, has increased interest in this analyte and its biomarkers as potential surrogates for 
total PAH exposure.   
In addition to Nap, studies have demonstrated the utility of Phe metabolites as 
biomarkers of PAH exposure (Carmella et al. 2004; Kim et al. 2005).  This stems in part 
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from the high relative levels of Phe in air samples, the predominant excretion of Phe in urine 
rather than feces, and the ability of Phe to be biotransformed and excreted in urine as a 
number of different metabolites (i.e., phenols, dihydrodiols, and tetraols).  Phenanthrene is 
the simplest PAH to contain a bay region, and, despite the fact that it is not a human 
carcinogen (IARC 1983; IARC 1987), Phe metabolism closely mimics that of BaP (Shou et 
al. 1994; Carmella et al. 2004).  Moreover, as with BaP, Phe is oxidized by various 
cytochrome P450s that may exhibit different regiospecificities (Jacob and Grimmer 1996).  
The ability to quantify various urinary metabolites of Phe may allow a better understanding 
of human metabolism of carcinogenic PAHs in vivo. 
 
1.2. Diesel exhaust 
Diesel exhaust (DE) is a complex mixture of gaseous and particulate species, the 
exact composition of which depends on the type of engine (light-duty vs. heavy duty), the 
type of fuel (high vs. low sulfur fuel), and engine operating conditions (idle vs. acceleration).  
Vapor-phase constituents of DE include atmospheric gases (e.g., nitrogen, oxygen, carbon 
dioxide, water vapor), oxides of sulfur and nitrogen, and volatile organic compounds (e.g., 
benzene and small PAHs).  Diesel particulate matter (DPM) consists of an elemental carbon 
core to which organic compounds (including PAHs) and inorganic compounds (e.g., nitrates, 
sulfates, and metals) are adsorbed.  DPM includes fine (< 2.5 µm) and ultrafine (< 0.1 µm) 
particles; these small particles penetrate to the deep lung following inhalation.  Consequently, 
following inhalation both gaseous and particle-adsorbed PAHs can diffuse into the 
bloodstream.   
 9
DE exposure in controlled human studies has been associated with cardiopulmonary 
changes including lung inflammation, altered vascular response, and cardiac ischemia 
(Stenfors et al. 2004; Mills et al. 2005; Mills et al. 2007).  In animal studies, DE exposure has 
been associated with respiratory tumors in rats (HEI 1995; EPA 2002).  Epidemiological 
evidence has repeatedly shown associations between occupational DE exposure and lung 
cancer (Bhatia et al. 1998; Lipsett and Campleman 1999).  Considering this evidence, DE is 
considered to be a probable human carcinogen (IARC 1989; EPA 2002).   
However, the mechanism whereby DE might cause cancer is unclear, and the 
relationship between DE exposure and response is clouded by the complexity of gaseous and 
particulate DE emissions, and the lack of quantitative exposure data (EPA 2002).  Measures 
of DE exposure that have been used in health effects studies include organic carbon (OC), 
elemental carbon (EC), and fine particulate matter (PM2.5 = particulate matter with 
aerodynamic diameters less than 2.5 µm) (Davis et al. 2006; Smith et al. 2006; Davis et al. 
2007).  Epidemiological studies of DE have also been complicated due to potential 
confounding by smoking (as well as other covariates) and the inability to discriminate diesel 
particles from those of non-diesel origins.   
There is also the lingering question as to whether DE exerts a carcinogenic effect via 
PAHs or by deposition of insoluble soot particles and reactive gases in the respiratory tract 
(EPA 2002).  Traditional measures of DE exposure (i.e., OC, EC, and PM2.5) have not 
clarified this uncertainty, mainly because they are not specific to DE, and don’t produce any 
identifiable biomarkers of exposure.  Recently, urinary PAH biomarkers (including OH-Pyr 
and metabolites of Nap and Phe) have been used to assess DE exposures (Nielsen et al. 1996; 
Hara et al. 1997; Seidel et al. 2002; Adonis et al. 2003; Kuusimaki et al. 2004).  While the 
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application of these PAH biomarkers has been promising, studies have been limited by small 
sample sizes, lack of analytical sensitivity and specificity, influence of PAH exposures from 
the diet and other unknown sources, and influence of smoking. 
 
1.3. Asphalt 
Asphalt is produced by the nondestructive distillation of crude oil during petroleum 
refining (NIOSH 2000).  Due to its adhesive properties, flexibility, durability, and water 
resistance, asphalt has been widely used in the road-paving industry as a binding agent for 
aggregate (i.e., sand, gravel, crushed stone, slag, and recycled concrete).  During road 
surfacing, workers are exposed to asphalt vapors (a product of heating), and particulate 
matter containing asphalt fumes (condensed vapor), as well as other constituents, via 
inhalation and dermal contact.  Although the composition of asphalt is variable, asphalt is a 
known source of occupational PAH exposure.   
Acute exposure to asphalt emissions is associated with irritation of the eyes, nose, 
throat, skin, and respiratory tissues, along with headaches, dizziness, fatigue, insomnia, 
nausea, and stomach discomfort (NIOSH 2000).  Additionally, occupational asphalt exposure 
has been associated with bronchitis, emphysema, and asthma (Hansen 1991).  
Epidemiological evidence suggests an increased risk of cancer among asphalt-exposed 
workers (Partanen and Boffetta 1994; Hooiveld et al. 2002; Burstyn et al. 2003; Randem et 
al. 2004; Boffetta et al. 1997).  However, the relationship between asphalt exposure and 
cancer risk is uncertain (Chiazze et al. 1991; NIOSH 2000).  This uncertainty stems from a 
lack of quantitative exposure measurements and the potential effects of covariates that 
influence asphalt exposures from airborne and dermal routes (NIOSH 2000). 
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In order to better characterize exposure to asphalt emissions, numerous exposure 
surrogates have been employed including air measurements of total particulate matter, the 
benzene-soluble fraction of total particulates, polycyclic aromatic compounds (PACs, which 
include unsubstituted PAHs and alkylated or otherwise substitiuted PAHs), and individual 
PAHs.  Some investigators have used dermal patches to quantify deposition of PAH-
containing particulate matter on the skin of asphalt-exposed workers (Jongeneelen et al. 
1988; McClean et al. 2004a; Vaananen et al. 2005).  Biomarkers of PAH exposure from 
asphalt emissions include Nap, Phe, and Pyr metabolites in urine (Vaananen et al. 2003; 
McClean et al. 2004b; Campo et al. 2006a; Campo et al. 2006b; Vaananen et al. 2006; 
Buratti et al. 2007; Campo et al. 2007).  Using urinary measurements, combined with 
measurements of the parent compounds in air and on the skin, investigators have 
demonstrated increased PAH exposure among asphalt workers.  Yet, uncertainty remains 
regarding the predominant exposure routes, rates of uptake and elimination of analytes, and 
the overall suitability of individual analytes as biomarkers of exposure to asphalt emissions. 
 
1.4. Specific goals of this project 
The primary aim of this study is to evaluate the suitability of Nap and Phe and their 
metabolites as urinary biomarkers of exposure to total PAHs.  This objective is broken down 
into the following specific goals: 
Specific Goal 1: Determine the predictive value of Nap and Phe as measures of exposure to 
diesel exhaust based on air measurements of diesel exhaust in a controlled chamber study 
(Paper 1). 
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Specific Goal 2: Determine the predictive value of urinary levels of Nap and Phe as 
surrogates for exposures to total PAHs in workers exposed to diesel exhausts, asphalt 
emissions (road paving and milling), and coke-oven emissions (steel industry) (Paper 2). 
Specific Goal 3: Use statistical models to evaluate the effects of work groups, tasks, timing 
of urine sampling, and other covariates on urinary levels of Nap and Phe and their 
metabolites among asphalt exposed workers (road paving) (Papers 3 and 4). 
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2. Paper I.  Identification of Surrogate Measures of Diesel Exhaust Exposure 
in a Controlled Chamber Study [Sobus, J.R., Pleil, J.D., Madden, M.C., Funk, W.E., 
Hubbard, H.F., Rappaport, S.M., submitted to Environmental Science and Technology, 
April, 2008.] 
 
 
2.1. Abstract 
 
Exposure to diesel exhaust (DE) has been associated with acute cardiopulmonary and 
vascular responses, chronic noncancer health effects, and respiratory cancers in humans.  To 
better understand DE exposures and eventually their related health effects, we established a 
controlled chamber experiment wherein human volunteer subjects were exposed to 
approximately 100 µg/m3 of DE.  In general, human exposure assessment for DE is based on 
ambient air measurements of surrogates such as elemental carbon (EC) or total organic 
carbon (OC) collected on filters.  As specific health effect mechanisms and dose response are 
obscured by the complex composition of DE, the linkage from exposure to internal dose can 
presumably be improved using specific biomarkers and metabolites in blood, breath, or urine.  
Because EC or OC are not suitable as biomarkers, in this study, we focus on identifying 
compounds that are demonstrated indicators of DE and can also be found in biological fluids.  
We measured an assortment of volatile, semi-volatile, and particle-bound aromatic 
compounds in the chamber air and report their airborne concentrations in DE and purified air, 
as well as the estimated values of the corresponding exposure ratios (mean DE air 
concentration: mean purified air concentration).  These estimated exposure ratios were used 
to identify naphthalene (Nap) and phenanthrene (Phe) as potentially useful surrogates for DE 
exposure that could also serve as biomarkers.  Estimated mean levels of Nap and Phe 
associated with the nominal 100 µg/m3 of DE were 2600 ng/m3 and 765 ng/m3 with estimated 
exposure ratios of 252 and 92.4, respectively.  Nap levels were significantly correlated with 
OC, and total particle-bound PAHs; Phe levels were significantly correlated with total 
volatile+semivolatile PAHs.  These results suggest that Nap and Phe may be particularly 
useful surrogates for DE concentrations.  While Nap and Phe are not validated here as 
internal biomarkers of DE exposure, we are currently assessing human biological specimens 
collected during this study, and will discuss those results in ensuing articles. 
 
2.2. Introduction 
Diesel exhaust (DE) is comprised of a mixture of gaseous and particulate 
contaminants, the exact composition of which depends upon the type of fuel, engine 
operating conditions, and other factors. Vapor-phase constituents of DE include atmospheric 
gases, oxides of sulfur and nitrogen, and volatile organic compounds.  Particulate matter 
emitted from diesel engines consists of an elemental carbon core to which a variety of 
organic and inorganic compounds are adsorbed.  Controlled human exposures to DE have 
been associated with cardiopulmonary changes including lung inflammation, altered vascular 
response, and cardiac ischemia (Stenfors et al. 2004; Mills et al. 2005; Mills et al. 2007).  
Chronic DE exposure has been associated with respiratory tumors in rats (HEI 1995; EPA 
2002) and lung cancers in occupational epidemiological studies (Bhatia et al. 1998; Lipsett 
and Campleman 1999).  Thus, DE is considered to be a probable human carcinogen (IARC 
1989; EPA 2002).   
Health effect mechanisms and dose-response relationships remain unclear due to the 
chemical complexity of DE and limited quantitative exposure data (EPA 2002).  
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Additionally, identification of susceptible subpopulations is not yet clear, further clouding the 
issue of effective dose (Gilliland et al. 2004).  To simplify the process of assessing exposures 
to DE, investigators have employed surrogate measures of particulate diesel emissions, 
including organic carbon (OC), elemental carbon (EC), and fine particulate matter (PM2.5 = 
particulate matter with aerodynamic diameters less than 2.5 µm) mass (Davis et al. 2006; 
Smith et al. 2006; Davis et al. 2007).  These particulate measures may not reflect the many 
potentially toxic aromatic constituents of DE, notably benzene (Ben) and a host of PAHs in 
the volatile fraction [e.g., naphthalene (Nap)], the semivolatile fraction [e.g., phenanthrene 
(Phe) and fluorene (Flu)], and the particle-bound fraction [e.g., benzo(a)pyrene (BaP) and 
chrysene (Chr)].  Therefore, the goal of this study was to characterize volatile, semivolatile, 
and particle-bound aromatic compounds in DE to identify useful exposure surrogates.  Here 
we present our sampling design and measurement techniques, descriptive statistics, and a 
correlation analysis to evaluate selected DE surrogates.   
 
2.3. Methods 
2.3.1. Study design 
All controlled chamber exposures took place at the EPA National Health and 
Environmental Effects Research Laboratory (NHEERL) Human Studies Facility in Chapel 
Hill, NC, with approval from the University of North Carolina at Chapel Hill Biomedical 
Institutional Review Board (IRB# 99-EPA-283  Title: Physiological, Cellular, and 
Biochemical Effects of Diesel Exhaust in Healthy Young Adults).  Ten volunteer subjects 
were exposed once to purified air and once to DE in a random and double-blind fashion, with 
two-hour exposure sessions separated by a minimum of three weeks.  Purified air used in 
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control exposures was drawn across activated charcoal to remove gaseous organic 
constituents, and high-efficiency particle absolute (HEPA) filters to remove particulates.  For 
DE exposures, exhaust was introduced into the chamber after an approximate 1:30 dilution 
with purified air.  The DE was generated from an idling six-cylinder, 5.9L-displacement 
diesel engine (Cummins, Columbus IN), mounted in a vehicle located outside of the human 
studies facility, which burned a certified diesel fuel (Chevron Phillips Chemical Company, 
Borger TX, 0.05 LS Certification Fuel, type II).  DE particulate levels were feedback-
controlled via an exhaust dilution manifold using real-time measurements given by a Tapered 
Element Oscillating Microbalance (ThermoFisher Scientific, Franklin, MA) and monitored 
using a DataRAMTM aerosol monitor (ThermoFisher Scientific, Franklin, MA).  Particle size 
was measured using a Scanning Mobility Particle SizerTM (TSI Inc., Shoreview, MN), and 
PM2.5 exposure concentration was determined using a Versatile Air Pollutant Sampler 
(VAPS) (URG, Chapel Hill, NC).  The volume median diameter (± SD) particle size over ten 
DE exposure periods was 0.10 ± 0.02 µm, and the estimated mean PM2.5 concentration was 
106.3 ± 8.6 µg/m3.  This concentration is comparable to levels encountered at busy 
intersections in large urban areas (EPA 2002).   
 
2.3.2. Collection and analysis of volatile aromatic compounds and  
2-4 ring PAHs 
 
Volatile aromatic compounds and 2-4 ring PAHs were sampled with custom-made 89 
mm x 6.4-mm (¼ in.) o.d. aluminum tubes containing 350 mg of 60-80 mesh Tenax®TA 
(Scientific Instrumentation Specialists, Inc., Ringoes, NJ) that was held in place with 
stainless steel screens.  The day prior to each chamber experiment, all adsorbent cartridges 
were cleaned by thermal desorption at 290ºC for 60 minutes with a constant helium flow 
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(99.999% purity) of 100 mL/min.  After cleaning, tubes were sealed using metal Swagelok® 
fittings and were stored overnight at room temperature.  Three adsorbent tubes were sampled 
in parallel inside the chamber for each two-hour exposure period at an air flow of 100 
mL/min.  At the conclusion of each experiment, adsorbent tubes were removed from the 
chamber, sealed with metal Swagelok® fittings, and stored at -20ºC prior to analysis (up to 
two weeks).  Air flow rates were calibrated both before and after air sampling, using a 
DryCal® DC-1 flow calibrator (Bios International Corp., Butler, NJ).   
Adsorbent tubes were thermally desorbed using a Markes Unity Thermal Desorber 
coupled to an Ultra Autosampler (Markes International, Ltd., Llantrisandt, UK), and analyzed 
using an Agilent 6890N gas chromatograph (GC) coupled to a 5973I mass spectrometer (MS)  
(Agilent, Santa Clara, CA).  Sample batches included two reagent blanks, three chamber 
samples, three field blanks, and two external standards containing all analytes of interest.  
Each sample tube was thermally desorbed at 260ºC for ten minutes, focused on a secondary 
trap at 0ºC for three minutes, and ballistically desorbed at a maximum temperature of 310°C 
for GC injection.  A 0.7-mm i.d. injector liner was used in the injection port of the GC, which 
was held at 250ºC and operated in the splitless mode with a pulse pressure of 103 kPa (15 
psi).  An RTX-5SILMS (Restek Corp., Bellefonte, PA) fused silica capillary column (60 m, 
0.25-mm i.d., 0.25-µm film thickness) was used with helium as the carrier gas at a flow rate 
of 1.1 mL/min.  After injection of the sample into the GC, the oven was held at 40°C for two 
minutes, and then ramped at a rate of 12°C/min to a final temperature of 300°C, where it was 
held for eight minutes.  The MS transfer line was held at 280°C, the source temperature at 
200°C, and the quadrupoles at 100°C.  The MS operated with electron ionization (EI) at an 
ionization voltage of 70 eV.  Analytes were identified using the selective-ion monitoring 
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(SIM) mode at m/z values summarized in Table 2.1. (first 17 analytes).  Quantitation was 
based on conversion of raw area counts into ng/sample values using external calibration 
standards while correcting for field blanks.  Air concentrations (ng/m3) were determined 
using the volume of air sampled by each tube.  Limits of quantitation (LOQ) were defined as 
three times the standard deviation of field-blank levels for each analyte.   
 
 
Table 2.1.  List of measured analytes with respective analytical parameters. 
 
  
chemical name 
 
abbreviation 
 
Methoda 
 
SIM ion (m/z)
 
LOQ (ng/sample)b 
 
LOQ (ng/m3)c 
      
benzene     Ben  TD GC-MS          78 1.48 123 
toluene     Tol TD GC-MS          91 3.19 264 
ethylbenzene     Etb TD GC-MS 106 0.63            52.3 
m,p-xylene     mp-xyl TD GC-MS 106 4.93 408 
styrene     Sty TD GC-MS 104 2.36 195 
o-xylene     o-xyl TD GC-MS 106 1.86 154 
4-ethyltoluene     Etol TD GC-MS 120 2.04 169 
1,3,5-trimethylbenzene     Tmb TD GC-MS 120 2.28 189 
1,2,4-trimethylbenzene     Tmb* TD GC-MS 120              10.7 885 
naphthalene     Nap TD GC-MS 128 0.32            26.6 
acenaphthalene     Anap TD GC-MS 152 0.09            7.09 
acenaphthene     Ace TD GC-MS 154 0.12            9.79 
fluorene     Flu TD GC-MS 166 0.25            20.4 
phenanthrene     Phe TD GC-MS 178 0.24            20.0 
anthracene     Ant TD GC-MS 178 0.18            15.0 
fluoranthene     Fla TD GC-MS 202 0.10            8.31 
pyrene     Pyr TD GC-MS 202 0.12            9.56 
      
benz[a]anthracene     BaA LE GC-MS 228 0.00004 0.00002 
chrysene     Chr LE GC-MS 228 0.00012 0.00006 
benzo[b]fluoranthene     BbF LE GC-MS 252 0.00147 0.00076 
benzo[k]fluoranthene     BkF LE GC-MS 252 0.00138 0.00072 
benzo[e]pyrene     BeP LE GC-MS 252 0.00157 0.00081 
benzo[a]pyrene     BaP LE GC-MS 252 0.00027 0.00014 
indeno[1,2,3-cd]pyrene     Ind LE GC-MS 276 0.00266 0.00138 
benzo[g,h,i]perylene     BgP LE GC-MS 276 0.00303 0.00157 
dibenz[a,h]anthracene     DaA 
 
LE GC-MS 278 0.00003 0.00002 
 
 
a TD GC-MS = thermal desorption coupled with gas chromatography-mass spectrometry. 
  LE GC-MS = liquid extraction coupled with gas chromatography-mass spectrometry. 
b Limit of quantitation in ng/sample calculated as three times the standard deviation of field-blank values. 
c  Limit of quantitation in ng/m3 assuming a 0.012 m3  air sample (avg. vol.) for TD GC-MS samples, and a 1.9 
m3  air sample (avg. vol.) for LE GC-MS samples. 
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2.3.3. Collection and analysis of particle-bound PAHs 
A VAPS was used to sample the chamber inflow airstream at an average rate of 15 
L/min for each two-hour exposure period.  Particulate matter, for analysis of particle-bound 
PAHs, was collected using a preweighed (±10% mass accuracy) 47-mm o.d. 2-µm 
polytetrafluoroethylene (PTFE) filter (Pall Life Sciences, Ann Arbor, MI).  At the end of 
each exposure period, the filter was reweighed to determine total mass.  Samples were stored 
at -20°C for up to six months prior to liquid extraction and GC-MS analysis.  Particle-bound 
PAHs were analyzed according to a previous method (Pleil et al. 2004) with minor 
modifications.  Each sample filter was excised from its polypropylene ring and placed in an 
8-mL extraction vial to which a 4-mL solution of HPLC-grade dichloromethane (Burdick & 
Jackson, Morristown, NJ) was added containing 4 ng of both ( H10)pyrene (Sigma-Aldrich, 
St. Louis, MO) and ( H12)benzo(e)pyrene (Cambridge Isotope Laboratories, Andover, MA) 
as internal standards.  Vials were capped, vortexed for 20 seconds, and then agitated at 300 
rpm for 90 minutes on an orbital shaker.  After agitation, filters were removed from the vials, 
and the extracts were reduced to 1 mL under high purity nitrogen gas (National Speciality 
Gases, Durham, NC).  The extracts were transferred into conical high-recovery autosampler 
vials (Agilent, Santa Clara, CA), and further reduced to 50 µL.  For increased storage 
stability, a solvent exchange was performed; 50 µL of HPLC-grade methanol (Fisher 
Scientific, Pittsburgh, PA) was added and the remaining dichloromethane was removed 
under nitrogen gas purge leaving approximately 50 µL final volume.  Samples were sealed 
with Teflon-lined septum crimp caps and were stored at -20°C under aluminum foil (light 
sensitivity) for up to one month prior to analysis by GC-MS.  Two µL of each sample extract 
was injected into an Agilent 6890N GC via a 7683 autoinjector connected to a 5973 MS 
2
2
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(Agilent, Santa Clara, CA).  Samples were injected using splitless mode with pulse pressure 
of 138 kPa (20 psi); the injection port contained a gooseneck liner with glass wool (Restek 
Corp., Bellefonte, PA, USA) held at 275°C.  An RTX-5SILMS (Restek Corp., Bellefonte, 
PA) fused silica capillary column (60 m, 0.25 mm-i.d., 0.25-µm film thickness) was used 
with helium as the carrier gas at a flow of 1.0 mL/min.  After injection of the sample into the 
GC, the oven was held at 50°C for three minutes, ramped at a rate of 25°C/min to a 
temperature of 150°C, and then ramped at a rate of 10°C/min to 300°C where it was held for 
24 minutes.  The MS transfer line was held at 280°C, the source temperature at 200°C, and 
the quadrupoles at 100°C.  The MS operated with EI at an ionization voltage of 70 eV.  Nine 
4-6 ring PAHs were detected using the SIM mode as summarized in Table 2.1.  Quantitation 
was based on peak areas of selected ions relative to the deuterated internal standard closest in 
molecular weight to the analyte of interest.  LOQs for each compound were defined as three 
times the standard deviation of field-blank levels  
 
2.3.4. Collection and analysis of OC, EC, and PM2.5 
 
During each exposure period, a VAPS configured with PTFE filters sampled PM2.5 
in the chamber inlet airstream.  Filters were weighed before and after sampling to determine 
total mass loadings.  The VAPS sampler operated at a flow rate of 15 L/min.  The average 
chamber concentration determined from duplicate filters was used for statistical analyses.  
One quartz fiber filter (Sunset Laboratory, Hillsborough, NC) sample was also collected 
during each exposure period and analyzed for OC and EC using NIOSH method 5040 
(NIOSH 1998a).   
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2.3.5.  Statistical Methods 
All statistical analyses were performed using SAS statistical software (v. 9.1, SAS 
Institute, Cary, NC), and all graphs were generated using GraphPad Prism software (v. 4, 
GraphPad Software, Inc., San Diego, CA).  For observations below detection limits (purified 
air exposures only), a value of LOD/ 2  was imputed (Hornung and Reed 1990; Pleil and 
Lorber 2007).  A total of 73 out of 1,148 total measurements were below detection limits, 
mainly for 4- to 6-ring PAHs.  These values were used to generate descriptive statistics for 
control chamber measurements only, and were not used in subsequent statistical analyses.  
Restricted maximum likelihood estimates of within- and between-day variance components 
were determined for selected analytes via Proc MIXED of SAS.  Values used in mixed-
effects modeling satisfied assumptions of normality (Shapiro-Wilks W test).  Spearman 
correlation coefficients, determined via Proc CORR of SAS, were used to estimate pairwise 
correlations among analytes.  For all tests, p < 0.05 (two-tailed) was determined to be 
statistically significant.  
 
2.4. Results and discussion 
2.4.1. Volatile aromatics and PAHs in DE and purified air 
 
Descriptive statistics for measured airborne analytes are presented in Table 2.2.  
Estimated mean exposure concentrations of measured analytes in DE are arranged in order of 
increasing magnitude, as shown by the black bars (from left to right), in Figure 2.1.  Air 
levels were lowest for particle-bound PAHs, while volatile & semivolatile PAHs had 
intermediate values, and volatile aromatic compounds had the highest concentrations.  Air 
concentrations of the particle-bound PAHs ranged from 0.068 ng/m3 for 
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dibenz[a,h]anthracene (DaA) to 0.346 ng/m3 for Chr; air concentrations for the volatile & 
semivolatile PAHs ranged from 17.1 ng/m3 for fluoranthene (Fla) to 2,600 ng/m3 for Nap; 
and air concentrations for the volatile aromatic compounds ranged from 3,160 ng/m3 for 
ethylbenzene (Etb) to 62,100 ng/m3 for 1,2,4-trimethylbenzene (Tmb*).   
For most analytes, measured concentrations in purified air were similar to field blank 
values (Table 2.2.).  Under the standard assumptions satisfying least squares linear regression 
of our calibration data (particularly linearity and homogeneity of variance), we calculated 
these low concentrations using comparisons to batch-wise analyses of control standards 
processed exactly as if they were regular samples at nominal “zero” and “span” levels.  
Ratios were calculated of the mean analyte air concentration in DE to the mean analyte 
concentration in purified air.  The calculation of the ratio parameter is used as one of two 
discriminators to differentiate a good from a poor potential DE surrogate.  Although a 
relatively high ratio may not be proof of a useful surrogate, a comparatively low ratio 
suggests discarding the compound, as it is difficult to differentiate even under the best of 
conditions.  The estimated values of these exposure ratios are shown in Figure 2.1. by the 
crosshatched bars.  The largest exposure ratios were observed for the particle-bound PAHs, 
which ranged from 27.2 for DaA to 288 for Chr, and the smallest exposure ratios were 
observed for the volatile aromatic compounds, which ranged from 0.776 for styrene (Sty) to 
58.5 for Ben.  In selecting chemical surrogates for DE exposure, it is desirable to select 
candidate compounds that are both abundant, to maximize detection, and which have high 
exposure ratios, suggesting that they are highly differentiated with respect to purified air.  
Our results indicate that although the volatile aromatic compounds were the most abundant, 
they had low exposure ratios and were, therefore, not highly differentiated from purified air.  
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Particle-bound PAHs, on the other hand, had large exposure ratios but had very low 
abundance, and would be difficult to detect in studies of health effects.  The compounds 
having the best combination of large abundance and large exposure ratios were the volatile & 
semivolatile PAHs, notably Nap and Phe.  
 
 
Table 2.2.  Mean levels (± SD) and ranges of analyes measured in chamber air. 
†  Gas- and gas + particle-phase compounds collected using adsorbent cartridges and analyzed using  
 
  
Diesel exhaust (ng/m3) 
 
Purified air (ng/m3) 
 
 
analyte 
 
phase† 
 
         mean ± SD 
 
min 
 
max 
 
         mean ± SD 
 
min 
 
max 
        
Ben gas          3330 ± 790 217 5130 56.9 ± 33.0 24.3 117 
Tol gas         3670 ± 1090 1970 5320           604 ± 376 177 1290 
Etb gas         3160 ± 929 1660 4180          76.6 ± 62.8 24.0 195 
mp-xyl gas       11800 ± 4660 4720 19600           624 ± 610 101 1830 
Sty gas         4910 ± 1410 3140 7210         6330 ± 3280 2290 13800 
o-xyl gas         4470 ± 1550 2080 6890           306 ± 379 33.4 1310 
Etol gas         6520 ± 3120 2190 12700           381 ± 571 39.6 1940 
Tmb gas       10500 ± 4060 4440 18100           717 ± 847 114 2970 
Tmb* gas       62100 ± 41000 17900 164000         3210 ± 5280 393 18000 
        
Nap gas + particle         2600 ± 658 1690 3630          10.3 ± 4.94 5.14 21.0 
Anap gas + particle           173 ± 48.5 69.8 232          2.21 ± 1.55 0.354 5.01 
Ace gas + particle           118 ± 19.6 96.7 150          3.40 ± 2.60 0.521 6.92 
Flu gas + particle           158 ± 50.8 72.9 236          5.14 ± 5.20 0.613 14.4 
Phe gas + particle           765 ± 181 507 1070          8.28 ± 4.60 1.32 17.7 
Ant gas + particle          78.6 ± 20.6 53.2 114          4.78 ± 4.37 0.392 10.6 
Fla gas + particle          17.1 ± 6.0 8.17 29.3          3.52 ± 2.75 0.291 7.69 
Pyr gas + particle          89.9 ± 35.8 34.0 145          6.86 ± 6.55 1.31 22.2 
        
BaA particle        0.239 ± 0.076 0.160 0.345      0.0010 ± 0.0018 0.00006 0.0056 
Chr particle        0.346 ± 0.100 0.220 0.525      0.0012 ± 0.0018 0.00021 0.0056 
BbF particle        0.307 ± 0.066 0.177 0.390      0.0037 ± 0.0062 0.00068 0.0190 
BkF particle        0.153 ± 0.037 0.0874 0.214      0.0019 ± 0.0033 0.00011 0.0100 
BeP particle        0.264 ± 0.036 0.195 0.309      0.0028 ± 0.0043 0.00015 0.0133 
BaP particle        0.341 ± 0.072 0.169 0.410      0.0036 ± 0.0053 0.00051 0.0163 
Ind particle        0.205 ± 0.066 0.103 0.320      0.0022 ± 0.0033 0.00092 0.0104 
BgP particle        0.233 ± 0.076 0.132 0.330      0.0023 ± 0.0026 0.00070 0.0084 
DaA 
 
particle        0.068 ± 0.029 0.0348 0.121      0.0025 ± 0.0048 0.00001 0.0139 
TD GC-MS; Particle-phase compounds were collected using active filter sampling and analyzed using  
LE GC-MS.   
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 Figure 2.1.  Air concentrations of volatile aromatics and PAHs in diesel exhaust, and corresponding exposure ratios.   
Data are arranged in order of increasing air concentration.  Black bars represent estimated mean diesel exhaust 
exposure concentrations (right y-axis); crosshatched bars represent estimated exposure ratios [(mean diesel exhaust 
air concentration: mean purified air concentration); left y-axis].  Error bars represent estimated SE.   
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2.4.2. Nap and Phe as surrogates for DE exposure 
Nap and Phe clearly stand out among volatile & semivolatile PAHs (see Figure 2.1.) 
due to their relatively high abundance (mean DE conc. = 2600 and 765 ng/m3, respectively) 
and large exposure ratios (252 and 92.4, respectively).  This finding supports results from 
previous observational studies in which air levels of Nap and Phe were relatively large among 
populations occupationally exposed to DE [i.e., truck drivers, maintenance workers and bus 
garage workers, and toll booth operators (Kuusimaki et al. 2002; Kuusimaki et al. 2003; Tsai 
et al. 2004)].  Table 2.3. compares the levels of Nap and Phe measured in our chamber 
experiments with the air concentrations from these earlier investigations.  Levels of Nap and 
Phe in chamber purified air were lower than those measured among literature reported control 
subjects (228 and 37 ng/m3, respectively).  Levels of Nap and Phe in chamber DE were very 
similar to those measured among bus garage workers (1023 and 568 ng/m3, respectively), and 
were higher than those measured among truck drivers (455 and 154 ng/m3, respectively) and 
maintenance workers (162 and 53 ng/m3, respectively).  Whereas Nap levels in chamber DE 
were lower than those measured among toll booth attendants (8850 ng/m3), Phe levels were 
higher in chamber DE compared to toll booth attendant exposure levels (264 ng/m3).  We 
note that Nap and Phe measurements among toll booth attendants reflect exposures from 
diesel and non-diesel sources (i.e., gasoline-powered engines).  As few studies have 
published individual Nap and Phe measurements from strictly diesel sources, the data are 
included here for a general comparison with our controlled exposure levels.      
Nap and Phe possess physiochemical properties that make them potentially desirable 
surrogates for DE.  Nap is generally the most abundant PAH measured from a given source 
(Rappaport et al. 2004).  Furthermore, because Nap exposure occurs almost entirely in the 
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vapor phase, it can be measured using passive adsorbent techniques (Egeghy et al. 2003).  
Such techniques eliminate the need for cumbersome and expensive sampling equipment, 
thereby increasing the ability to obtain more air measurements at a given cost for studies of 
health effects (Rappaport 1991).  Nap also offers several potentially useful biomarkers of 
PAH exposure, including unmetabolized Nap in urine (Waidyanatha et al. 2003; Campo et al. 
2006a), several urinary metabolites (Serdar et al. 2003b; Serdar et al. 2004; Wu et al. 2005), 
and protein adducts of the naphthoquinones (metabolites of Nap) in human serum albumin 
(Waidyanatha et al. 2004).  Finally, since Nap is classified as a possible human carcinogen 
(IARC 2002), it is useful to characterize human exposures to Nap per se.  Phenanthrene is 
also abundant in PAH exposure scenarios, both in vapor and particle-bound phases.  Vapor-
phase Phe can presumably be measured in air using passive adsorbent techniques.  While Phe 
is not classified as a human carcinogen (IARC 1983; IARC 1987), its metabolism follows 
closely to that of carcinogenic PAHs (Shou et al. 1994; Carmella et al. 2004); numerous Phe 
metabolites can be measured in human urine as biomarkers of PAH exposure (Hecht et al. 
2003; Carmella et al. 2004; Kim et al. 2005).   
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Table 2.3. Comparison of Nap and Phe levels in studies involving diesel exhaust 
exposure. 
 
 
 
                Study 
 
      Exposure Group 
     
       Air Nap (ng/m3) 
  
     Air Phe (ng/m3) 
    
Kuusimaki et al. 2002    Truck drivers a,b      455     (175 - 2500)      154   (20 -1135) 
    Maintenance workers a,b      162     (50 - 476)      53     (< 20 - 395) 
    Controls a,b      228     (100 - 510)      37     (< 20 - 215) 
    
Kuusimaki et al. 2003    Bus garage workers a,b      1023   (204 - 3362)      568   (43 - 2664) 
    Controls a,b      228     (100 - 510)      37     (< 23 - 215) 
    
Tsai et al. 2004     Toll booth attendants c      8850   (5040 - 12300)      264   (111 - 422) 
    
This Study    Diesel exhaust exposure      2600   (1690 - 3630)      765   (507 - 1070) 
    Purified air exposure   < 27   < 20 
 
Mean exposure levels and ranges reported 
a  Mean values of combined winter and summer data 
b Gas-phase measurements only 
c Values reflect vehicle engine emissions including those from diesel sources 
 
 
2.4.3. Variability assessment for Nap and Phe 
The mean levels of Nap and Phe across ten DE exposure days were 2600 ng/m3 and  
765 ng/m3, and the standard deviations were 658 ng/m3 and 181 ng/m3, respectively.  These 
standard deviations reflect the dispersion of ten individually averaged values specific to each 
exposure day, and serve as a measure of the between-day exposure variability.  For volatile & 
semivolatile PAHs including Nap and Phe, three measurements were made on each exposure 
day, allowing the simultaneous assessment of within-day and between-day variability.  
Estimates of within-day variability are assumed to represent assay variability across three 
replicate samples; between-day estimates represent variability in daily DE exposure levels.  
Calculation of the intraclass correlation coefficient [ICC = $σ b2 / ( $σ w2 + $σ b2); where $σ b2 
represents the estimated between-day variance component and $σ w2 represents the estimated 
within-day variance component of the total estimated variance (i.e. $σ w2 + $σ b2 = $σ 2)] allows 
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assessment of the relative variability between exposure days to total measured variation.  For 
Nap in DE, the majority of total measured variation came between exposure days (ICC = 
0.91).  In fact, subjects exposed to DE on days 5, 6, 9, and 10 received Nap exposures 
significantly different than the overall group mean (Figure 2.2.A).  For Phe, about one third 
of the total measured variation came between exposure days (ICC = 0.36), and no subjects 
were identified as receiving Phe exposures significantly different than the group mean 
(Figure 2.2.B).  Within-day variability estimates were nearly identical for Nap and Phe 
(Nap: $σ w2 = 39200; Phe: $σ w2 = 37400) suggesting uniform assay variability for these 
analytes.  All measurements of Nap and Phe made during purified air exposures were 
determined to be indistinguishable from field-blank values, and were therefore not considered 
in this assessment of sources of variability. 
 B)
1 2 3 4 5 6 7 8 9 10
0
500
1000
1500
Phe
Intraclass correlation coefficient = 0.36
group mean (765 ng/m3)
Exposure day
A
ir 
C
on
c 
(n
g/
m
3 )
A) 
1 2 3 4 5 6 7 8 9 10
0
1000
2000
3000
4000
5000
* * *
*
Nap
* significantly different than group mean (α = 0.05)
group mean (2600 ng/m3)
Intraclass correlation coefficient = 0.91
Exposure day
A
ir 
C
on
c 
(n
g/
m
3 )
Figure 2.2.  Chamber measurements of Nap (A) and Phe (B) across ten diesel 
exhaust exposure days.  Each bar represents the day-specific mean exposure 
level.  Error bars (SE) represent variability across three measurements per day.  
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2.4.4. Correlations among surrogate measures of DE exposure 
Although chamber DE exposures were highly regulated based on real-time particulate 
measurements, individual analytes associated with DE displayed variability.  While this 
variability was very modest compared to that observed in environmental and occupation 
settings (Lin et al. 2005), significant daily variations in individual analyte levels were 
observed.  In considering Nap and Phe as potential surrogates for DE exposure, it is 
particularly useful to compare the air concentrations of Nap and Phe with those of accepted 
measures of particulate exposure, namely, OC, EC, and PM2.5, as well as with the combined 
air concentrations of PAHs in the particle-bound phase [containing the most carcinogenic 
compounds (IARC 1983; IARC 1987)].  Figure 2.3. shows a correlation matrix, for the 
estimated mean air levels of Nap, Phe, OC, EC, PM2.5, total volatile aromatics, total 
volatile+semivolatile PAHs (minus Nap and Phe), and total particle-bound PAHs, for the ten 
subjects exposed to DE in our study (only measurements made during actual DE exposures 
were included in this correlation analysis).  Air concentrations of Nap were significantly 
correlated with OC (r = 0.85; p = 0.0016), EC (r = -0.71; p = 0.022) and particle-bound 
PAHs (r = 0.67; p = 0.033).  The negative correlation between Nap and EC mirrors that 
which was observed between OC and EC [r = -0.64; p = 0.048 (not shown in Figure 2.3.)].  
As DE is composed of an elemental carbon core with adsorbed organics, it stands to reason 
that when the total mass is held constant (as was the case during our controlled exposures), 
the EC and OC components of total mass should be negatively correlated.  While EC is a 
useful DE exposure surrogate in occupational studies (Zaebst et al. 1991; Davis et al. 2006; 
Smith et al. 2006; Davis et al. 2007), the positive correlations between Nap and OC, and 
between Nap and total particle-bound PAHs, suggests that Nap may be a particularly good 
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surrogate for the organic constituents of DE.  This finding is even more interesting when 
considering that air levels of Nap have previously been shown to be highly correlated with 
those of total PAHs in studies of workers in the steel and aluminum industries where PAH 
levels are particularly high (Rappaport et al. 2004).  In addition to the observed Nap 
correlations, a highly significant pairwise correlation was observed between concentrations of 
Phe and total volatile+semivolatile PAHs (r = 0.96; p < 0.0001), suggesting that Phe may 
also be a useful surrogate for selected organic DE constituents.   
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             Figure 2.3. Correlations among constituents of diesel exhaust; total DE mass was feedback regulated to achieve  
             100 µg/m3. 
                    
                 Nap = naphthalene; Phe = phenanthrene; OC = organic carbon; EC = elemental carbon; PM2.5 = fine particulate matter  
                x- and y-axes represent % deviation from mean exposure level (n =10) 
r = Spearman’s rho; p = p -value
 
 
2.4.5. Concluding remarks 
 Nap and Phe are promising surrogate markers for the broad spectrum of airborne 
constituents resulting from DE sources.  They are both abundant in DE and highly 
differentiated in trace-level measurements with respect to purified ambient air.  In addition, 
Nap and Phe are easily measured in air and can also be assayed as biomarkers of exposure.  
Although the chamber concentrations were highly regulated based on real-time particulate 
measurements, individual analytes associated with DE displayed variability.  We attribute 
this to small differences in organic enrichment of the particles, stemming from subtle 
changes in truck engine performance and weather conditions.  Despite this observed 
variability, significant positive correlations between concentrations of Nap and other DE 
markers (i.e., OC and total particle-bound PAHs), and between Phe and total 
volatile+semivolatile PAHs, suggest that Nap and Phe could serve as quantitative markers for 
DE concentrations in future health effects studies and epidemiological risk assessments.  We 
caution that all of the common DE markers may have other environmental sources as well, 
and that other meta-data will be important for assessing their relative contributions.  
However, we conclude from this work that Nap and Phe are optimal surrogates if a direct 
comparison between biomarker and external source is sought.  We are currently assessing a 
series of metabolic biomarkers and response parameters in human biological specimens 
collected during this study and will discuss those results in ensuing articles. 
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3. Paper II.  Urinary Naphthalene and Phenanthrene as Biomarkers of 
Occupational Exposure to Polycyclic Aromatic Hydrocarbons [Sobus, J.R.,  
Waidyanatha, S., McClean, M.D., Herrick, R.F., Smith, T.J., Garshick, E.,  
Laden, F., Hart, J.E., Zheng, Y., Rappaport, S.M., submitted to Occupational  
and Environmental Medicine; provisional acceptance, June 2008.]  
3.1. Abstract 
Objectives: We investigated the utility of unmetabolized naphthalene (Nap) and 
phenanthrene (Phe) in urine as surrogates for exposures to mixtures of polycyclic aromatic 
hydrocarbons (PAHs).   
Methods: Our study included workers exposed to diesel exhausts (low PAH exposure level, 
n = 39) as well as those exposed to emissions from asphalt (medium PAH exposure level, n = 
26) and coke ovens (high PAH exposure level, n = 28).  Levels of Nap and Phe were 
measured in urine from each subject using head space-solid phase microextraction and gas 
chromatography-mass spectrometry.  Published levels of airborne Nap, Phe, and other PAHs 
in the coke-producing and aluminum industries were also investigated. 
Results: In post-shift urine, the highest estimated geometric mean concentrations of Nap and 
Phe were observed in coke-oven workers (Nap: 2,490 ng/l; Phe: 975 ng/l), followed by 
asphalt workers (Nap: 71.5 ng/l; Phe: 54.3 ng/l), and by diesel-exposed workers (Nap: 17.7 
ng/l; Phe: 3.60 ng/l).  After subtracting logged background levels of Nap and Phe from the 
logged post-shift levels of these PAHs in urine, the resulting values [referred to as ln(adjNap) 
and ln(adjPhe), respectively] were significantly correlated in each group of workers (0.71 ≤ 
Pearson r ≤ 0.89), suggesting a common exposure source in each case.  Surprisingly, multiple 
linear regression analysis of ln(adjNap) on ln(adjPhe) showed no significant effect of the 
source of exposure (coke ovens, asphalt, and diesel exhaust) and further suggested that the 
ratio of urinary Nap/Phe (in natural scale) decreased with increasing exposure levels.  These 
results were corroborated with published data for airborne Nap and Phe in the coke-
producing and aluminum industries.  The published air measurements also indicated that Nap 
and Phe levels were proportional to the levels of all combined PAHs in those industries. 
Conclusion: Levels of Nap and Phe in urine reflect airborne exposures to these compounds 
and are promising surrogates for occupational exposures to PAH mixtures.   
 
3.2. Introduction 
Polycyclic aromatic hydrocarbons (PAHs) comprise a class of chemicals composed of 
two or more fused aromatic rings.  Since PAHs are produced by the incomplete combustion 
of organic matter, including petroleum, coal, and other carbonaceous materials (e.g. wood, 
tobacco products, food products), they are ubiquitous contaminants of the human 
environment.  Humans are exposed to PAHs via inhalation, ingestion, and dermal contact.  
Moderate to high-level PAH exposures stemming from coke ovens, aluminum production, 
and asphalt use have been associated with cancers of the lung, skin, and bladder (Boffetta et 
al. 1997).  Exposure to diesel exhausts, containing lower levels of PAHs, has been associated 
with increased lung cancer risks (Bhatia et al. 1998; Lipsett and Campleman 1999).  
The quantitative assessment of PAH exposure has been complicated by the large 
number of individual compounds in a given mixture and by the presence of PAHs in both the 
gas phase (2-ring and 3-ring compounds) and the particulate phase (4-ring to 6-ring 
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compounds).  While certain particulate-phase PAHs (notably benzo(a)pyrene) have been 
classified as known or probable human carcinogens (IARC 1983; IARC 1987), air 
concentrations of these 4-6 ring PAHs tend to be very low and difficult to measure.  
Recently, attention has focused upon the more abundant gas-phase PAHs, notably 
naphthalene (Nap, two rings) and phenanthrene (Phe, three rings), as possible surrogates for 
PAH exposure (Jacob and Seidel 2002; Rappaport et al. 2004).  Naphthalene is typically the 
most abundant PAH measured from a given source (Rappaport et al. 2004), and air levels of 
Nap tend to be highly correlated with the sum of all measured PAH levels (hereafter ‘total 
PAHs’) in workplaces (Rappaport et al. 2004).  Since Nap is a known carcinogen of the lung 
in rodents (Abdo 1992; NTP 1992; NTP 2000; Abdo et al. 2001), it is important to 
characterize human exposure to Nap per se.  Phenanthrene is also present at high 
concentrations in PAH emissions and, while not classified as a carcinogen, is the smallest 
PAH to contain a bay region, a feature closely associated with carcinogenicity (Shou et al. 
1994; Carmella et al. 2004).   
Small amounts of Nap and Phe are eliminated unchanged in the urine (Waidyanatha 
et al. 2003).  Here we report levels of unmetabolized Nap and Phe in urine from workers 
exposed to three sources of PAHs that had been classified a priori as having low, medium, 
and high levels of PAHs, namely, diesel-exhausts, asphalt emissions, and coke-oven 
emissions, respectively (Brandt and Watson 2003).  We show that urinary levels of Nap and 
Phe in these workers followed the expected low, medium, and high designations of the 
sources, and that they were highly correlated, suggesting a common source of exposure to 
Nap and Phe in each group.  We further compare results from measurements of urinary Nap 
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and Phe with published data representing air concentrations of Nap, Phe, and total PAHs in 
the coke-producing and aluminum-producing industries (Bjorseth et al. 1978a; Bjorseth et al. 
1978b; Petry et al. 1996; Strunk et al. 2002). 
 
3.3. Methods 
3.3.1. Chemicals and supplies 
Naphthalene (99+%), phenanthrene (99.5%), (2H8)naphthalene (98+%), 
(2H10)phenanthrene (98+%), and methanol (purge and trap grade) were obtained from 
Aldrich Chemical Company (Milwaukee, WI).  Sodium chloride was obtained from Fisher 
Scientific (Pittsburgh, PA).  Head space-solid phase microextraction (HS-SPME) supplies 
were obtained from Supelco (Bellefonte, PA) and MicroLiter Analytical Supplies, Inc. 
(Suwanee, GA). 
 
3.3.2. Sources of urine samples and published air measurements 
Post-shift urine samples were obtained from 28 coke-oven workers (15 top workers 
and 13 side and bottom workers) and 22 control workers (office and hospital workers) from a 
single steel-producing complex in Northern China.  Since levels of Nap and Phe had 
previously been determined in urine from these subjects (Serdar et al. 2003b; Waidyanatha et 
al. 2003), here we compare the original data with those obtained from other groups of 
workers in the current investigation.  Urine samples were also obtained from 26 asphalt 
workers in road paving crews in the Northeastern U.S. (McClean et al. 2004a; McClean et al. 
2004b).  This group included 20 paving workers who applied hot mix asphalt to roads, and 
six milling workers who removed old asphalt from roads.  Urine samples were collected from 
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asphalt workers on either two (milling workers) or three consecutive days (paving workers) 
both before and after work shifts, starting at the beginning of the work week.  Finally, urine 
samples were obtained from 39 diesel-exposed workers who performed various tasks in 
trucking terminals throughout the U.S. (Davis et al. 2006; Smith et al. 2006).  (While workers 
in trucking terminals may have experienced PAH exposures from ambient air, diesel exhaust 
is believed to be their primary source of PAH exposure, and we refer to this group as ‘diesel-
exposed workers’ for simplicity).  This group included 27 loading-dock workers who drove 
propane forklifts and loaded trailers, 8 truck-repair-shop workers involved with truck 
maintenance and refueling activities, and 4 office workers who had only background 
exposure to diesel exhausts.  Pairs of urine samples were collected from each diesel-exposed 
worker before and after a work shift.  The smoking status of all workers was obtained by 
questionnaire. 
Air levels of Nap, Phe, and total PAHs were derived from published data reporting 
exposures in the coke-producing and aluminum industries.  The data were previously 
summarized by Rappaport et al. (Rappaport et al. 2004), who focused upon Nap exposures.  
For this analysis, we consider air levels of both Nap and Phe that were reported along with 
various other PAHs in several workplaces.  The data include 32 measurements (area, 
breathing-zone, and personal samples) for up to 39 PAHs in a coke production plant 
(Bjorseth et al. 1978b), three measurements (grouped personal samples from 24 individuals) 
for 16 PAHs in a coke-production plant (Strunk et al. 2002), 28 measurements (including 
area and personal samples) for up to 36 PAHs in an aluminum reduction plant (Bjorseth et al. 
1978a), and six measurements (midrange of five personal samples from 6 workers) for 26 
PAHs in a carbon anode plant (Petry et al. 1996).   
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All subjects included in this study provided informed consent to participate according 
to protocols approved by ethics committees at the Harvard University School of Public 
Health (Boston, Massachusetts, U.S.A.) and the Institute for Occupational Medicine (Beijing, 
China).   
 
3.3.3. Analysis of urinary naphthalene and phenanthrene 
Urine samples from asphalt and diesel-exposed workers were analyzed for Nap and 
Phe as previously described, with minor modifications (Waidyanatha et al. 2003).  Samples 
were stored at either -20°C or -80°C prior to analysis.  After thawing, 0.7-ml portions were 
transferred into 2-ml crimp top vials containing 0.3 g of NaCl.  Urine samples were spiked 
with 1.0 µl of an internal standard mixture containing (2H8)Nap and (2H10)Phe in methanol, 
to give a final concentration of 0.5 µg/l of urine.  Samples were immediately capped and 
stored at -20°C for up to 24 h prior to analysis.  Prior to use, vials, caps, and NaCl were 
conditioned at 160°C to remove background Nap and Phe. 
Headspace solid-phase microextraction (HS-SPME) was performed to extract Nap 
and Phe from urine using a CombiPal autosampler (CTC Analytics, Zwingen, Switzerland).  
Prior to analysis, samples were brought to room temperature, and were incubated at 55°C for 
three minutes.  Analytes were sampled from urine headspace using a PDMS fiber (10 mm, 
100-µm film thickness).  Adsorption and desorption times were 30 and 20 min, respectively.  
Levels of Nap and Phe were measured with a model 6890N gas chromatograph (GC) coupled 
to a model 5973N mass spectrometer (MS) (Agilent, Palo Alto, CA).  The MS was operated 
with electron impact ionization at an ionization voltage of 70eV.  The MS transfer line was 
maintained at 280°C, the source temperature at 200°C, and the quadrupole at 100°C.  A DB-
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1 (J&W Scientific Inc., Folsom, CA) fused silica capillary column (60 m, 0.25-mm i.d., 0.25-
µm film thickness) was used with He as the carrier gas.  A 0.75-mm i.d. SPME injection 
sleeve was used in the injector port, with the temperature maintained at 250°C.  The GC oven 
was held at 75°C for 8 min, and then ramped at 5°C/min to 260°C, where it was held for ten 
min.  Ions selected for analysis included m/z 128 (Nap), m/z 136 [(2H8)Nap], m/z 178 (Phe), 
and m/z 188 [(2H10)Phe].  Quantitation was based on response ratios of the analytes to the 
corresponding internal standards [(2H8)Nap or (2H10)Phe].  Standard curves were prepared 
with pooled urine from human volunteers, which had been spiked with Nap and Phe at 
concentrations of 0.40, 2.0, 10, 25, 50, 75, and 100 ng/l and the same levels of internal 
standards used for experimental samples.  The estimated coefficients of variation for Nap and 
Phe were 0.25 and 0.26, respectively, and the estimated limit of detection (LOD) was 0.40 
ng/l for each analyte.  Two observations, with analyte levels below the LOD, were assigned 
levels of LOD/ 2  for statistical analyses. 
 
3.3.4. Statistical analyses 
 Statistical analyses were performed after (natural) logarithmic transformation of 
urinary levels, to remove heteroscedasticity and satisfy normality assumptions, using SAS 
statistical software (v. 9.1, SAS Institute, Cary, NC).  A p-value < 0.05 was considered 
significant (two-tailed test).  For asphalt workers, subject-specific means of logged pre-shift 
and post-shift Nap and Phe levels (from urine samples collected on two or three consecutive 
days) were used for statistical analyses.  General linear models were used with dummy 
variables to test for effects on analyte levels of the source of exposure (diesel exhausts, 
asphalt emissions, and coke-oven emissions), the job category (coke-top, coke-side, coke-
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control, asphalt-paver, asphalt-miller, diesel-office, diesel-shop, and diesel-dock workers), 
smoking status, and interaction terms for job category and smoking status (Proc GLM).  
Correlation and regression analyses of subject-specific urinary analyte levels were based 
upon background-adjusted values as follows:  Since asphalt and diesel-exposed workers had 
paired pre-shift and post-shift urine samples, background adjustment was performed by 
subtracting logged pre-shift analyte levels from logged post-shift analyte levels.  Background 
adjustment for coke-oven workers, who had only post-shift urine samples, was performed by 
subtracting the mean logged level estimated in factory control workers from the logged level 
observed for each coke-oven worker.  Since background adjustment was based upon 
subtraction of logged pre-shift or control values of Nap and Phe from logged post-shift 
values, the adjusted values, designated adjNap and adjPhe, in natural scale, represent the 
ratios of post-shift analyte levels to pre-shift or control levels.  Pairwise correlations between 
ln(adjNap) and ln(adjPhe) were estimated using Pearson correlation coefficients (Proc 
CORR).  Least squares multiple linear regression was used to investigate the relationship 
between ln(adjNap) and ln(adjPhe) using dummy variables to test for effects of worker group 
and job category (Proc REG).  Individual observations were investigated as possible outliers 
based upon influence as measured by leverage, Studentized residuals, Cook’s distance, and 
change in adjusted R2.  Considering these criteria, one observation (out of a total of 93 
observations) was rejected from the final model (removing this outlier increased the adjusted 
R2 of the final model by 7.7%).  Least squares multiple linear regression was also used to 
investigate the relationship between logged air concentrations of Nap and Phe using dummy 
variables for sources of exposure (coke- and aluminum-producing industries) (Proc REG).  
Three observations of air data (out of a total of 85 observations) were not included in the 
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analysis, because they were reported as containing little or no Nap and/or Phe in the gas 
phase, a physical impossibility for the environments in question.   
 
3.4. Results and discussion 
3.4.1. Effects of job category on urinary analyte levels 
Summary statistics [geometric means (GMs), geometric standard deviations (GSDs), 
and numbers of subjects] of Nap and Phe levels in pre-shift urine samples (asphalt and 
diesel-exposed workers only) and post-shift urine samples are presented in Table 3.1., for 
workers classified by source of PAHs and job category.  Results from general linear models 
showed a significant effect of job category on Nap and Phe levels in both pre-shift (p < 
0.0005) and post-shift urine (p < 0.0001).  After adjustment by job category, smoking status 
did not significantly affect Nap and Phe levels in either pre-shift or post-shift urine (p > 
0.05).   
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Table 3.1. Urinary naphthalene and phenanthrene levels a for workers grouped by 
source of PAHs and job category.  
 
aGeometric mean (geometric standard deviation) levels are displayed. 
 
   Naphthalene Level (ng/l) Phenanthrene Level (ng/l)
Source of PAHs Job Category 
No. 
Subjects Pre-shift  Post-shift Pre-shift Post-shift 
 
Diesel exhausts Dock workers 27 21.2 (1.69) 17.1 (1.71) 3.39 (2.02) 2.67 (1.87) 
 Office workers 4 14.9 (1.51) 18.0 (1.42) 4.05 (2.20) 5.18 (1.40) 
 
Shop workers 
 
8 
 
13.0 (1.55) 
 
19.6 (2.28) 
 
4.40 (2.16) 
 
8.20 (2.31) 
 
 
Asphalt emissions  Asphalt milling workers 6 33.3 (1.30) 34.4 (2.01) 10.1 (2.01) 23.8 (2.87) 
 
Asphalt paving workers 
 
20 
 
32.3 (1.90) 
 
89.1 (1.90) 
 
11.0 (2.61) 
 
69.6 (2.01) 
 
 
Coke-oven 
emissions  
Office and hospital 
workers (factory controls) 22 NA 765 (2.31) NA 58.2 (3.27) 
 
Coke-oven workers (side 
and bottom) 13 NA 1710 (3.39) NA 735 (4.56) 
 
Coke-oven workers  
(top ) 
 
         15 
 
          NA 
 
   3450 (5.14) 
 
         NA 
 
 1250 (7.65) 
 
Legend: NA = not available. 
 
 
Significant differences in pre-shift urine levels suggest job-specific variations in 
background exposures stemming from variability in ambient air exposures, diet, lifestyle 
factors, and/or geographic location.  The post-shift data point to an approximate 200-fold 
range of Nap levels and a 470-fold range of Phe levels across the different job categories, 
with the highest levels observed in the top coke-oven workers and the lowest levels observed 
in the diesel-exposed workers.  The ranks of observed Nap and Phe levels are consistent with 
a priori reports of PAH exposures (Brandt and Watson 2003), where coke-oven workers had 
the highest concentrations (top > side and bottom > steel-factory controls) (Serdar et al. 
2003b; Waidyanatha et al. 2003), followed by asphalt workers (paving > milling) (McClean 
et al. 2004a; McClean et al. 2004b), followed by diesel-exposed workers.  We note that the 
asphalt workers’ Nap and Phe levels in urine are very similar to median levels measured by 
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Campo et al. in road paving workers and road construction workers (Campo et al. 2006a; 
Campo et al. 2007).  We also note that the control workers from the Chinese steel-making 
complex had higher levels of Nap and Phe in their urine than even the asphalt workers, 
indicating a significant source of background exposure to PAHs in the air of that factory. 
 
3.4.2. Background-adjusted levels of urinary naphthalene and phenanthrene 
Summary statistics for Nap and Phe levels are shown in Table 3.2. by source of 
PAHs, after adjustment for background concentrations of Nap and Phe.  Because (in natural 
scale) the adjusted values represent ratios of post-shift levels to background levels, values of 
adjNap and adjPhe of approximately one for diesel-exposed workers imply little difference 
between post-shift and background levels for a typical subject.  Adjusted post-shift levels for 
asphalt workers indicate an approximate 2-fold and 5-fold increase over background levels 
for Nap and Phe, respectively and results for coke-oven workers suggest 3-fold and 17-fold 
increases over background levels for Nap and Phe, respectively.  While background-adjusted 
values follow the same rankings as the unadjusted levels of Nap and Phe (coke-oven workers 
> asphalt workers > diesel-exposed workers), the ranges are considerably smaller, i.e., about 
3-fold for adjNap and 17-fold for adjPhe.  This reflects the large range of background levels 
of Nap and Phe observed for each worker group.  (We recognize that our use of the large 
median values of urinary Nap and Phe measured in factory controls to adjust the 
corresponding urinary levels for the Chinese coke-oven workers could have introduced 
uncertainty into this analysis).  Since Nap is typically the most abundant PAH measured from 
a given source (Rappaport et al. 2004), the larger adjPhe values suggest greater urinary 
excretion of Phe compared to Nap and/or lower relative background concentrations of Phe 
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compared to Nap.  This result is consistent with previous results estimating the percentages 
of excreted Nap and Phe in the coke oven-workers to be 4 and 13%, respectively, of the 
urinary levels of the metabolites of these PAHs (Waidyanatha et al. 2003). 
 
 
Table 3.2. Background-adjusted levels of naphthalene and phenanthrene in the urine of 
groups of workers exposed to PAHs from three different sources.  [These background-
adjusted values represent the ratios of levels of naphthalene and phenanthrene in post-
shift urine to either pre-shift urine levels (diesel-exhaust and asphalt sources) or 
factory-control urine levels (coke-oven source)].  
  Adjusted Naphthalene Level (ratio of post-shift level to background level) 
Adjusted Phenanthrene Level (ratio 
of post-shift level to background level) 
Source of PAHs No. Subjects GM (GSD) Min. Max. GM (GSD) Min. Max. 
 
Diesel exhaust  
 
39 0.959 (2.00) 0.159 7.61 0.989 (2.74) 0.228 17.5 
 
Asphalt 
 
26 2.20 (2.19) 0.651 10.4 5.04 (3.35) 1.21 219 
 
Coke ovens  
 
28 3.26 (4.38) 0.144 32.8 16.7 (6.06) 0.228 330 
 
 
  Legend: GM = geometric mean; GSD = geometric standard deviation. 
 
 
3.4.3. Relationships between urinary levels of naphthalene and  
          phenanthrene 
 
Significant correlations between ln(adjNap) and ln(adjPhe) levels were observed in 
all three groups of workers (p < 0.0001), suggesting common sources of exposure to Nap and 
Phe in each case.  Pearson correlation coefficients for ln(adjNap) and ln(adjPhe) increased 
from r = 0.71 for diesel-exposed workers, to r = 0.82 for asphalt workers, to r = 0.89 for 
coke-oven workers (one outlier excluded).   
Multiple linear regression analyses of ln(adjNap) on ln(adjPhe) showed no significant 
effect of the source of PAHs (coke ovens, asphalt, diesel exhaust) or the job category (p > 
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0.05).  Since the sources of PAH were dramatically different, this finding was unexpected.  
However, it is clear from Figure 3.1. that the overall relationship between ln(adjNap) and 
ln(adjPhe) was essentially the same for each of the three groups of workers.  Figure 3.1. also 
shows that the intra-group variability of the data pairs [ln(adjNap), ln(adjPhe)] was very large 
for each of the three sources of PAHs.  The final regression model (after removal of one 
outlier) is given as: ln(adjNap) = -0.121 + 0.551×ln(adjPhe) (n = 92), with an adjusted R2  
value of 0.751.  The log-scale regression coefficient of 0.551, with 95% confidence limits of 
[0.485, 0.617], was significantly less than one.  This suggests that, in natural scale, the ratio 
of Nap/Phe diminished with increasing levels of Phe.   
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Figure 3.1. Logged background-adjusted naphthalene level in urine [ln(adjNap)]  
regressed on the corresponding logged background-adjusted phenanthrene level 
[ln(adjPhe)].  Diamonds represent diesel-exposed workers; circles represent  
asphalt workers; asterisks represent coke-oven workers.  Overall regression  
equation: ln(adjNap) = -0.121 + 0.551[ln(adjPhe)]; adjusted R2 = 0.751.   
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3.4.4. Relationships between air levels of naphthalene, phenanthrene, and  
 total PAHs  
           
In selecting Nap and Phe as possible surrogates for PAH exposure, it is important that 
urinary levels accurately reflect air concentrations of total PAHs at the time of urine 
collection.  Rappaport et al. (Rappaport et al. 2004) reported high correlations between 
logged levels of airborne Nap and logged levels of total airborne PAH in published data from 
several industries, namely, creosote impregnation (Pearson r = 0.815), coke production (r = 
0.917), an iron foundry (r = 0.854), and aluminum production (r = 0.933).  Furthermore, the 
estimated slopes of the log-scale relationships between ln(Nap) and ln(total PAHs) ranged 
from 0.824 to 1.19, indicating that air concentrations of Nap were roughly proportional to 
those of total measured PAHs in each case.   
Using the same data previously analyzed by Rappaport et al. (Rappaport et al. 2004) 
we investigated the straight-line relationships between logged levels of airborne Phe and 
logged levels of total PAHs.  Datasets reporting air Phe levels were only available in studies 
of the aluminum-producing and coke-producing industries (Bjorseth et al. 1978a; Bjorseth et 
al. 1978b; Petry et al. 1996; Strunk et al. 2002).  Across four datasets, 60 out of 66 
observations of total PAH levels included measurements of Phe.  We note that, for studies 
from Bjorseth et al. (Bjorseth et al. 1978a; Bjorseth et al. 1978b) some observations specified 
both gaseous and particulate air levels, while others specified only particulate levels.  We 
distinguished between these types of observations in Figure 3.2., where we examined the log-
log relationships of Phe and total PAHs.  As shown in Figure 3.2., the estimated slopes of the 
log-log relationships were 1.09 and 1.15 for aluminum-producing and coke-producing 
industries, respectively, indicating that levels of airborne Phe were roughly proportional to 
those of total PAHs in these industries.   
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Figure 3.2.  Air phenanthrene concentration (µg/m3) vs. total PAH concentration 
(µg/m3) (minus phenanthrene concentration) in aluminum-production facilities (A)  
and coke-production facilities (B).  Closed triangles: data from  
(Bjorseth et al. 1978a) (gas+particulate measurements); open triangles:  
data from (Bjorseth et al. 1978a) (particulate measurements only); plus symbols:  
data from (Petry et al. 1996); closed circles: data from (Bjorseth et al. 1978b) 
(gas+particulate measurements); open circles: data from (Bjorseth et al. 1978b) 
(particulate measurements only); ×: data from (Strunk et al. 2002).  
 
We used these same data (Bjorseth et al. 1978a; Bjorseth et al. 1978b; Petry et al. 
1996; Strunk et al. 2002) to investigate the relationship between air concentrations of Nap 
and Phe in the aluminum-producing and coke-producing industries.  The final analysis 
included six observations from (Bjorseth et al. 1978b), 15 observations from (Bjorseth et al. 
1978a), three observations from (Strunk et al. 2002), and six observations from (Petry et al. 
1996).  As shown in Figure 3.3., the relationship between air Nap and air Phe is given by the 
regression model: ln[Nap (µg/m3)] =  0.723 + 0.769×ln[Phe (µg/m3)] + 1.50[source]; where 
coke-production source = 1 and aluminum-production source = 0.  A significant effect of the 
source of exposure indicates that the ratio of airborne Nap/Phe was greater in coke-producing 
industries when compared to aluminum-producing industries.  Since the overall regression 
coefficient for ln(Nap) on ln(Phe) was significantly less than one, with an estimated value of 
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0.769 and 95% confidence interval [0.607, 0.931], we infer that ratio of airborne Nap/Phe (in 
natural scale) decreased with increasing air levels of Phe, consistent with results based upon 
the urinary data (see Figure 3.1.).  This finding lends indirect support to the conjecture that 
urinary levels of Nap and Phe reflect the corresponding air levels of these compounds in 
occupational settings at the time of urine collection.  Our results support those from a recent 
study by Campo et al. (Campo et al. 2007), which showed that measurements of urinary Nap 
and Phe in highway construction workers and asphalt workers were highly correlated with 
personal airborne exposures to these compounds. 
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Figure 3.3. Log-transformed air concentration (µg/m3) of naphthalene [ln(Nap)] 
regressed on the corresponding logged air concentration (µg/m3) of phenanthrene 
[ln(Phe)] in the coke-producing and aluminum-producing industries.  Closed 
circles: data from (Bjorseth et al. 1978b) and (Strunk et al. 2002); open circles: 
data from (Bjorseth et al. 1978a) and (Petry et al. 1996).  Overall regression 
equation: ln(Nap) = 0.723 + 0.769[ln(Phe)] + 1.50[source]; where coke-production 
source = 1 and aluminum-production source = 0; adjusted R2 = 0.796. 
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3.5. Conclusions 
We conclude that levels of Nap and Phe in urine from diesel-exposed workers, 
asphalt workers, and coke-oven workers followed the expected low, medium, and high 
exposure designations, and were highly correlated with each other, suggesting common 
sources of the two PAHs.  Regression analyses of ln(adjNap) values on the corresponding 
ln(adjPhe) values showed no significant effect of the source of PAH in these three cases.  
Furthermore, these analyses indicated that the ratio of urinary Nap/Phe decreased with 
increasing levels of urinary Phe.  Since the ratio of airborne Nap/Phe was also found to 
decrease with increasing airborne Phe, in independent sets of data from the coke-producing 
and aluminum-producing industries, we conclude that urinary levels of Nap and Phe very 
likely reflect the corresponding levels of airborne Nap and Phe at the time of urine collection.  
Also, we observed that air concentrations of Nap and Phe were both proportional to total 
PAHs in the coke-producing and aluminum-producing industries.  Taken together, these 
findings, plus the ease and sensitivity of measuring Nap and Phe in urine, lead us to conclude 
that urinary levels of Nap and Phe are promising surrogates for occupational exposures to 
total PAHs.  Of the two urinary analytes, Phe may be a more useful surrogate than Nap, 
given the much larger fold increases above background values observed for Phe (one to 17-
fold) compared to Nap (one to 3-fold) across the three sources of PAHs in our study (see 
Table 3.2.). 
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4. Paper III.  Analysis of Urinary Biomarkers of Asphalt Exposure Using  
Mixed Models [Sobus, J.R., McClean, M.D., Herrick, R.F., Waidyanatha,  
S., Onyemauwa, F., Kupper, L.L., Rappaport, S.M., to be submitted to Annals  
of Occupational Hygiene] 
 
4.1. Abstract 
 
Hot-mix asphalt used in the road-paving industry is known to contain polycyclic 
aromatic hydrocarbons (PAHs).  Individual PAH biomarkers have been used to represent 
internal dose through inhalation and dermal routes of exposure.  We investigated urinary 
biomarkers of naphthalene [urinary naphthalene (U-Nap) and total hydroxynaphthalene (OH-
Nap)], phenanthrene [urinary phenanthrene (U-Phe) and total hydroxyphenanthrene (OH-
Phe)], and pyrene [1-hydroxypyrene (OH-Pyr)] in a group of 26 highway construction 
workers; 20 workers were involved with the application of hot-mix asphalt (pavers), and 6 
were involved in road removal processes (millers).  Our analysis included baseline urine 
samples, as well as postshift, bedtime, and morning samples collected over three consecutive 
days.  Overall, significant pairwise correlations between all biomarkers suggest common 
exposure sources.  In baseline samples, no significant differences in biomarker levels were 
observed between pavers and millers, suggesting similar background exposures.  For millers, 
postshift, bedtime, and morning biomarker levels were not significantly elevated over 
baseline levels.  For pavers, all biomarkers were significantly elevated in postshift samples, 
indicating rapid uptake and elimination following occupational asphalt exposure.  Biological 
half-times were estimated to be 8 h for U-Phe, 10 h for U-Nap, 13 h for OH-Phe and OH-Pyr, 
and 26 h for OH-Nap.  Results from linear mixed-effects models showed significant effects 
of work tasks on levels of U-Nap, U-Phe, OH-Phe, and OH-Pyr.  While no task-related 
effects were observed for OH-Nap, cigarette-smoking status significantly affected OH-Nap 
levels.  These results support the use of U-Nap, U-Phe, OH-Phe, and OH-Pyr, but probably 
not OH-Nap, as short-term biomarkers of exposure to PAHs emanating from asphalt. 
 
4.2. Introduction 
Asphalt, a byproduct of petroleum refining, has been widely used in the road-paving 
industry.  When hot asphalt is applied to roads, workers are exposed to gaseous and 
particulate emissions via inhalation and dermal contact.  These emissions include polycyclic 
aromatic hydrocarbons (PAHs), some of which are known or suspected carcinogens (IARC 
1987).  Epidemiological evidence suggests an increased risk of cancer among asphalt-
exposed workers (Partanen and Boffetta 1994; Hooiveld et al. 2002; Burstyn et al. 2003; 
Randem et al. 2004; Boffetta et al. 1997).  However, the relationship between occupational 
exposures and cancer risk is not well defined in this population (Chiazze et al. 1991; NIOSH 
2000).  The inability to characterize associations between asphalt-derived PAH exposures 
and cancer stems, in part, from a lack of quantitative exposure data and the presence of 
confounding variables that influence exposures from airborne and dermal routes (Chiazze et 
al. 1991; NIOSH 2000). 
To better understand asphalt exposures and related health effects, efforts have focused 
on biomarkers of exposure, such as unmetabolized PAHs and PAH metabolites in urine, 
which represent internal doses of PAHs through multiple exposure routes.  Such biomarkers 
may be good indicators of total PAH exposure for use in epidemiologic studies.  Indeed, a 
urinary metabolite of pyrene (Pyr) [namely 1-hydroxypyrene (OH-Pyr)] has been shown to 
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reflect asphalt exposure (Jongeneelen et al. 1988; McClean et al. 2004b; Campo et al. 
2006b), and is regarded as a ‘gold standard’ for a general assessment of PAH exposure.  
More recently, naphthalene (Nap) and phenanthrene (Phe) have been identified as potential 
PAH-exposure surrogates.  Urinary levels of unmetabolized Nap (U-Nap) and Phe (U-Phe) 
(Campo et al. 2006a; Campo et al. 2007), and of hydroxylated Nap and Phe metabolites 
(Vaananen et al. 2003; Vaananen et al. 2006; Buratti et al. 2007), have been shown to reflect 
occupational exposures to asphalt emissions.  (Hereafter, the sum of 1- and 2-
hydroxynaphthalene will be referred to as ‘OH-Nap’ and the sum of 2-, 3-, 4-, and 9-
hydroxyphenanthrene will be referred to as ‘OH-Phe’).  However, the rates of uptake and 
elimination of these biomarkers are uncertain and the influence of covariates on urinary 
analyte levels has not been thoroughly examined. 
In a previous analysis of 26 highway construction workers, the relationship between 
asphalt exposure and urinary OH-Pyr was evaluated using distributed lag models (McClean 
et al. 2004b).  Results showed that OH-Pyr concentrations in paving workers were 
significantly affected by inhalation and dermal Pyr exposure.  Here, we extend the analysis to 
include selected biomarkers of Nap and Phe.  Our objectives are to: 1) characterize urinary 
levels of Nap, Phe, and Pyr biomarkers in asphalt-exposed workers; 2) assess correlations 
between measured analytes; 3) evaluate the influence of sample collection time on urinary 
analyte levels; 4) estimate the rate of elimination of each analyte from the body; and 5) 
evaluate the influence of covariates [creatinine, time, workday, work task, smoking, age, and 
body mass index (BMI)] on urinary analyte levels.   
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4.3. Methods 
4.3.1. Study population and design 
Specific details of this study population and design have been published (McClean et 
al. 2004a; McClean et al. 2004b).  Here we considered 26 male highway construction 
workers residing in the Greater Boston area of the U.S.  Workers were recruited with 
informed consent according to a protocol reviewed for the protection of human subjects at 
Harvard University.  Twenty workers were involved with the application of hot-mix asphalt 
on road surfaces (hereafter ‘pavers’) and 6 workers were involved in road removal processes 
(hereafter ‘millers’).  Since the millers did not work with hot-mix asphalt, they were included 
in this analysis as a reference group.  The pavers consisted of workers from four task 
categories, namely paver operators, screedmen, rakers, and roller operators.  Paver operators 
drove the paving machines, screedmen were positioned on a platform at the rear of the paving 
machines, rakers followed closely behind the paving machines to fill holes, and rolling 
operators drove rolling machines to smooth and compact the asphalt.  Over a three-day period 
of evaluation, starting at the beginning of the workweek, urine samples were collected from 
all workers, before work (morning), after work (postshift), and at bedtime of each day.  
Morning samples collected on the first day of the workweek (after a work-free weekend) 
were treated as baseline samples.  Overall, seven urine samples were collected from each 
milling worker (two sampling days), and ten urine samples were collected from each paving 
worker (three sampling days).  All urine samples were collected in sterilized polypropylene 
containers and stored at -20˚C for up to seven years prior to analysis.  Covariate information 
(e.g., age, height, weight, smoking status) was obtained by questionnaire.  Creatinine levels 
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were determined using a colorimetric procedure (Procedure No. 555, Sigma Diagnostics, 
Dorset, UK) (Sigma Chemical Co. 1984). 
 
4.3.2.  Analysis of urinary naphthalene and phenanthrene 
A detailed description of this procedure is described elsewhere (see Chapter 3, section 
3.3.3.).  Briefly, Nap and Phe were extracted from urine using solid-phase microextraction 
and analyzed using gas chromatography-mass spectrometry.  Standard curves were prepared 
by spiking Nap, Phe, and an internal standard mixture [(2H8)Naphthalene and 
(2H10)Phenanthrene] into pooled urine collected from anonymous nonsmoking unexposed 
volunteers.  Quantitation of U-Nap and U-Phe in the samples was based on response ratios 
with respect to the corresponding internal standards. 
 
 
4.3.3. Analysis of urinary PAH metabolites 
 
A detailed description of this procedure is in preparation.  Briefly, hydroxy-PAHs 
(OH-PAHs) were enzymatically digested using β-glucuronidase/arylsulfatase (Roche 
Diagnostics, Indianapolis, IN), extracted from urine using solid-phase extraction (EnvirElute 
PAH cartridges, Varian, Palo Alto, CA), and analyzed via liquid chromatography-tandem 
mass spectrometry using a Surveyor LC system (Thermo Fisher Scientific, San Jose, CA) 
and a TSQ Quantum Ultra triple quadrupole mass spectrometer (Thermo Fisher Scientific, 
San Jose, CA).   A Thermoelectron Gold 3µm C18 column (Thermo Fisher Scientific, San 
Jose, CA, 150 X 2.1 mm) was used for analyte separation with a flow rate of 250 µl/min.  
Methanol and water were used as the mobile phase with a gradient of 55% to 81.8% 
methanol over 25 min.  After holding the column for 10 min at 97% methanol, it was 
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equilibrated to 55% methanol/45% water for 10 min.  The following product ion masses were 
observed: 115.09 m/z for 1- and 2- hydroxynaphthalene (1- and 2-OHNap, respectively), 
165.08 m/z for 2-, 3-, 4-, and 9-hydroxyphenanthrene (2-, 3-, 4-, and 9-OHPhe, respectively), 
and 189.08 m/z for OH-Pyr.  Calibration curves were prepared by adding standards and a 
mixture of isotopically labeled internal standards into pooled urine collected from 
anonymous nonsmoking unexposed volunteers.  Quantitation of 1- and 2-OHNap, 2-, 3-, 4-, 
and 9-OHPhe, and OH-Pyr were based on response ratios with respect to the corresponding 
internal standards [(2H8)1-hydroxynaphthalene, (13C6)3-hydroxyphenanthrene, and (2H8)1-
hydroxypyrene]. 
 
 
4.3.4. Statistical methods 
For all statistical analyses, levels of 1- and 2-OHNap, and levels of 2-, 3-, 4-, and 9-
OHPhe were summed, and are presented here as OH-Nap and OH-Phe, respectively.  Urinary 
analyte data were evaluated using SAS statistical software (v. 9.1, SAS Institute, Cary, NC) 
after natural log-transformation to satisfy normality assumptions and to remove 
heteroscedasticity.  Due to the repeated-measures sampling design, linear mixed-effects 
models (Proc MIXED) were used to estimate correlation coefficients between analytes 
according to Hamlett et al. (Hamlett et al. 2003).  To test the effects of work group and 
sample type on analyte levels, baseline data (one measurement per subject) were analyzed 
using general linear models (Proc GLM), and postshift, bedtime, and morning data (repeated 
measures), were assessed using linear mixed-effects models (Proc MIXED).  A p-value < 
0.05 was considered significant (two-tailed test).  Mixed models were used to assess 
covariate influence [creatinine (g/l), time (h), work task, workday, age (y), BMI (kg/m2), and 
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smoking status (current smoker vs. nonsmoker)] on analyte levels.  Rather than dividing 
analyte concentration by creatinine concentration, creatinine was included as an independent 
variable in the multivariable models to allow analyte levels and other covariates to be 
adjusted for variations in urine dilution (Barr et al. 2005).  To assess time effects, postshift 
measurements were assigned values of 0 h, and bedtime and morning measurements were 
assigned values representing the times after the postshift urine samples were collected 
(bedtime median = 6.00 h, bedtime range = 2.50 - 14.3 h; morning median = 15.3 h, morning 
range = 11.8 - 19.1 h).  Elimination rate constants (k) and biological half-times (T1/2 = -
0.693/k) were estimated using the regression coefficients for time after adjusting for 
significant covariates.  Multivariable mixed models were evaluated using manual backwards 
stepwise elimination at a significance level of α = 0.10.  Bayesian Information Criterion 
(BIC) diagnostic values were used to select between competing models. A compound 
symmetry covariance matrix was used in all mixed-effects models.  This covariance structure 
generally yielded the lowest BIC values compared to those yielded by other tested matrices 
(homogeneous autoregressive, heterogeneous autoregressive). 
 
4.4. Results 
4.4.1. Descriptive statistics and correlation analysis for urinary analytes 
Summary statistics [geometric means (GMs), geometric standard deviations (GSDs), 
and numbers of observations] for urinary analytes, categorized by work group and sample 
type, are displayed in Table 4.1. 
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Table 4.1. Descriptive statistics for urinary analytes (ng/L) measured in pavers and 
millers. 
 
n = number of observations 
 
*** significantly different from baseline level (p < 0.0001) 
** significantly different from baseline level (p < 0.05) 
* marginally different from baseline level (p < 0.10) 
Analyte Work Group n      GM        (GSD) n      GM           (GSD) n      GM          (GSD) n      GM         (GSD)
U-Nap pavers 20   29.6        (2.31) 58   92.0 ***    (2.13) 54   48.7 **     (2.28) 56   36.8         (2.14)
millers 6   36.1        (1.43) 11   34.4           (2.13) 9   31.2          (1.70) 9   26.4         (1.51)
U-Phe pavers 20   9.16        (3.12) 58   70.8 ***    (2.61) 54   32.4 ***   (3.46) 56   13.5         (3.40)
millers 6   14.9        (3.12) 11   24.7           (3.34) 9   12.8          (3.51) 9   6.56         (2.11)
OH-Nap pavers 19   9200       (3.42) 55   17600 *** (2.45) 52   12500 *    (2.94) 54   10500      (2.87)
millers 6   11000     (2.16) 11   9510          (2.93) 9   4580         (3.11) 9   3830        (2.86)
OH-Phe pavers 19   1640       (2.26) 55   7930 ***   (2.14) 52   4750 ***  (2.73) 54   2400 **   (2.20)
millers 6   1380       (1.89) 11   1850          (2.39) 9   1690         (2.68) 9   1240        (2.36)
OH-Pyr pavers 19   375         (3.43) 55   2110 ***   (2.63) 52   1130 ***  (4.02) 54   708 **     (3.63)
millers 6   323         (3.79) 11   536 *         (3.97) 9   484           (3.01) 9   367          (3.64)
Baseline Postshift Bedtime Morning
 
Overall, OH-Nap was the most abundant urinary analyte (median = 12,100 ng/l) followed by 
OH-Phe (median = 3,500 ng/l), OH-Pyr (median = 1,130 ng/l), U-Nap (median = 42.3 ng/l) 
and finally U-Phe (median = 29.7 ng/l).  The geometric means of urinary analyte levels were 
greater for pavers than for millers in postshift, bedtime, and morning samples.  Figure 4.1. 
shows a correlation matrix including pairwise comparisons of all analytes.  Significant 
correlations between all pairs were observed, suggesting common exposure sources for all 
analytes.  The strongest associations were observed between OH-Phe and OH-Pyr (r = 0.90), 
between U-Phe and OH-Phe (r = 0.84), and between U-Nap and U-Phe (r = 0.80).  Although 
still statistically significant, weaker associations were observed when comparing OH-Nap to 
other analytes (r ≤ 0.53).  We note that levels of OH-Pyr measured here were highly 
correlated with the original OH-Pyr measurements from McClean et al. (r = 0.89, p < 0.0001) 
(McClean et al. 2004b), indicating good agreement between studies. 
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       U-Phe          OH-Nap                 OH-Phe         OH-Pyr 
      U-Nap 
      U-Phe 
     OH-Nap 
    OH-Phe 
 r = 0.51 
 p = 0.008 
 r = 0.84 
 p < 0.0001 
 r = 0.74 
 p < 0.0001 
 r = 0.65 
 p = 0.0003 
 r = 0.73 
 p < 0.0001 
 r = 0.49 
 p = 0.011 
 r = 0.80 
 p < 0.0001 
 r = 0.53 
 p = 0.005 
 r = 0.44 
 p = 0.02 
 r = 0.90 
 p < 0.0001 
     Figure 4.1. Pairwise correlations between urinary analytes. 
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4.4.2. Effects of work group and sample type on urinary analyte levels 
 
In baseline urine samples, results from general linear models showed no significant 
effect of work group on urinary analyte levels (p-value ≥ 0.37).  When we considered all 
other sample types (i.e., postshift, bedtime, and morning measurements), a significant work 
group effect was observed after adjusting for sample type (p-value < 0.05 for U-Nap, U-Phe, 
OH-Phe and OH-Pyr; p-value = 0.07 for OH-Nap).  Table 4.1. displays group-specific 
geometric mean levels of urinary analytes for each sample type.  For millers, neither 
postshift, bedtime, nor morning analyte levels were significantly elevated over baseline 
levels (p-value ≥ 0.09).  For pavers, levels of OH-Phe and OH-Pyr were significantly 
elevated above baseline levels in postshift samples (p-value < 0.0001), bedtime samples (p-
value < 0.0001), and morning samples (p-value ≤ 0.02) while levels of U-Nap and U-Phe 
were significantly elevated in postshift samples (p-value < 0.0001) and bedtime samples (p-
value ≤ 0.005).  For OH-Nap, the increase in postshift levels over baseline levels was highly 
significant (p-value < 0.0001) while the increase in bedtime levels over baseline levels was 
marginally significant (p-value = 0.07). 
 
4.4.3. Linear mixed-effects models for urinary analytes 
 
Linear mixed-effects models were used to estimate elimination rate constants for each 
analyte, to analyze task-specific differences in analyte levels, and to assess the influence on 
analyte levels of urine dilution (as indicated by levels of urinary creatinine), workday, 
smoking status, age, and BMI.  Observations from millers were not included in this analysis 
because preliminary results showed no effect of occupational exposure on analyte levels (see 
Table 4.1.).  Additionally, as morning measurements of U-Nap, U-Phe, and OH-Nap from 
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pavers were not significantly elevated above baseline levels (see Table 4.1.), only postshift 
and bedtime measurements were included in the final models.  Table 4.2. shows estimated 
parameters from linear mixed-effects models for each urinary analyte.  In each model, a 
significant positive effect of urinary creatinine concentration was observed (p-value < 
0.0001), indicating increased analyte levels with decreased urine flow.  After adjusting for 
creatinine concentration, a significant negative effect of time was observed for each analyte 
(p-value ≤ 0.01), indicating a decrease in analye levels from the time of postshift urine 
collection to bedtime.  Using estimated elimination rate constants, T1/2 values (and 95% 
confidence intervals) were estimated to be 7.70 h (5.17 h, 15.1 h) for U-Phe, 10.2 h (7.07 h, 
17.8 h) for U-Nap, 13.3 h (7.79 h, 46.2 h) for OH-Pyr, 13.6 h (9.00 h, 27.7 h) for OH-Phe, 
and 25.7 h (14.1 h, 116 h) for OH-Nap.   
 After adjusting for time, a significant work task effect was observed for U-Nap, U-
Phe, OH-Phe, and OH-Pyr.  These results (shown in Table 4.2.) indicate that analyte levels 
were lower in roller operators compared to paver operators, screedmen, and rakers.  When 
roller operators were removed from the multivariable models, no significant work task effect 
was observed (p-value ≥ 0.5). 
 
 
 
 
 
 
 63
Table 4.2. Results from the linear mixed-effects models evaluating urinary analytes in paving workers. 
Parameters   Estimate   (SE)   p- value   Estimate   (SE)   p- value   Estimate   (SE)   p- value   Estimate   (SE)   p- value   Estimate   (SE)   p- value
Fixed effects
intercept    3.04      (0.331)   <0.0001   2.03      (0.413)    0.0002   9.68      (0.317)   <0.0001   6.91      (0.288)  <0.0001   5.25      (0.457)  <0.0001
creatinine (g/l)    0.550    (0.111)   <0.0001   0.652    (0.159)  <0.0001   0.554    (0.085)   <0.0001   0.639    (0.100)  <0.0001   0.830    (0.145)  <0.0001
time (h)   -0.068    (0.015)   <0.0001  -0.090    (0.022)    0.0001  -0.027    (0.011)     0.01  -0.051    (0.013)    0.0002  -0.052    (0.019)    0.007
task     0.09     0.003     0.3   <0.0001     0.02
      paver operator    0.724    (0.379)    0.918    (0.440)    0.141    (0.360)    0.960    (0.316)    0.857    (0.537)
      screedmen    0.782    (0.335)   1.33      (0.390)   0.565    (0.324)   1.25      (0.280)   1.21      (0.475)
      raker    0.648    (0.306)   1.26      (0.356)   0.343    (0.303)   1.29      (0.257)   1.39      (0.435)
      roller operator    0           (ref.)    0           (ref.)    0           (ref.)    0           (ref.)    0           (ref.)
workday     0.004 NS NS     0.02     0.09
      day 1   -0.398   (0.125)   -0.305    (0.117)   -0.362    (0.164)
      day 2   -0.065   (0.127)   -0.033    (0.119)   -0.170    (0.168)
      day 3    0          (ref.)    0            (ref.)    0            (ref.)
smoker NS NS   <0.0001 NS NS
      no   -0.160    (0.256)
      yes    0            (ref.)
Random effects
between-subject (σ2B)    0.194    0.210    0.190    0.127    0.406
within-subject (σ2W)    0.279    0.648    0.148    0.223    0.440
  OH-Pyr  U-Nap   U-Phe   OH-Nap   OH-Phe
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Figure 4.2.A-E shows baseline analyte levels along with postshift and bedtime analyte levels 
over three consecutive days.  As no work task effect was observed across paver operators, 
screedmen, and rakers, the mean values of these combined workers, along with the mean 
values of roller operators, are displayed at each time point.  The task-based differences in 
analyte levels between roller operators and all other paving workers are apparent for all 
analytes except OH-Nap (Figure 4.2.C).  Increases in analyte levels (p-value < 0.1) over each 
workday were also observed for U-Nap (Figure 4.2.A), OH-Phe (Figure 4.2.D), and OH-Pyr 
(Figure 4.2.E).  While no work task or workday effect was observed for OH-Nap, a highly 
significant smoking effect was observed, with smokers having higher analyte levels than 
nonsmokers (Table 4.2.).  No other analytes were significantly affected by smoking status.  
Neither body mass index (BMI) nor age were significantly associated with postshift and 
bedtime analyte levels. 
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Figure 4.2. Estimated mean concentration (ng/l) and 95% confidence intervals of 
urinary analytes over time.  Closed squares represent paver operators, screedmen, 
and rakers; open squares represent roller operators.  Urinary analytes:  
(A) Naphthalene; (B) Phenanthrene; (C) OH-Naphthalene; (D) OH-Phenanthrene; 
(E) OH-Pyrene.  
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4.5. Discussion 
Assessing occupational exposures to asphalt emissions has largely focused upon the 
content of carcinogenic PAHs, such as benzo(a)pyrene (IARC 1987).  Although some 
relationships between airborne exposures to PAHs and urinary PAH biomarkers have been 
examined (Vaananen et al. 2003; McClean et al. 2004b; Campo et al. 2006a; Campo et al. 
2006b; Vaananen et al. 2006; Buratti et al. 2007; Campo et al. 2007), questions remain 
regarding the rates of uptake and elimination for individual PAHs and influence of 
covariates, such as work groups and tasks on analyte levels.  To address these questions, we 
analyzed five PAH biomarkers in the urine of 26 road construction workers using a repeated-
measures sampling design (McClean et al. 2004a; McClean et al. 2004b).  Linear mixed-
effects models were used to estimate elimination rates for individual analytes, to evaluate 
work-group-related and task-related differences in analyte levels, and to determine the 
influence on analyte levels of urine dilution (measured by creatinine level), smoking status, 
BMI, and age.  
Urinary concentrations of U-Nap, U-Phe, OH-Nap, OH-Phe, and OH-Pyr were 
comparable to those reported in other occupational studies of asphalt exposure (Campo et al. 
2006a; Campo et al. 2006b; Buratti et al. 2007; Campo et al. 2007).  Overall, OH-Nap was 
the most abundant urinary analyte, followed by OH-Phe, OH-Pyr, U-Nap, and finally U-Phe.  
Our results indicate that the concentration of U-Nap was approximately 3.5% of OH-Nap, 
and the concentration of U-Phe was 8.5% of OH-Phe (not including 1-hydroxyphenanthrene, 
which was not measured).  These results agree with those observed in a previous study of 
coke-oven workers (Waidyanatha et al. 2003).   
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Overall, significant pairwise correlations between analyte levels suggest common 
exposure sources for Nap, Phe, and Pyr in asphalt workers.  In baseline samples collected on 
the morning of the first day of the workweek, no differences in analyte levels were observed 
between pavers and millers.  This indicates that similar background exposures, from the 
ambient environment and the diet, dominated PAH biomarkers in both of these groups of 
workers.  Considering postshift, bedtime, and morning measurements in millers, no 
significant increases above baseline levels were observed for any analyte.  This result was 
expected because millers did not work with hot asphalt and, generally, had low levels of 
exposure to PAHs (McClean et al. 2004a; McClean et al. 2004b).  For pavers, the largest 
departures from baseline levels were observed in postshift samples (see Table 4.1.).  A 
comparison of geometric mean levels showed that U-Phe was the most sensitive biomarker, 
with postshift levels approximately 7-fold greater than baseline levels.  Postshift levels of 
OH-Phe and OH-Pyr were approximately 5-fold greater than baseline levels, and postshift 
levels of U-Nap and OH-Nap were approximately 3- and 2-fold greater than baseline levels, 
respectively. 
Results from our final linear mixed-effects models showed that urinary creatinine was 
significantly associated with each urinary analyte.  The positive regression coefficients 
suggest that as creatinine concentration increased analyte concentration also increased, 
indicating elevated analyte concentration with reduced urine output.  This result was 
expected for OH-Nap, OH-Phe, and OH-Pyr, because these compounds are removed from 
the body via renal filtration.  However, the significant positive effect of creatinine on U-Nap 
and U-Phe was unexpected.  Unmetabolized volatile organic compounds are thought to be 
eliminated by passive diffusion (Ghittori et al. 1993; Waidyanatha et al. 2001; Serdar et al. 
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2003a).  As the elimination rates of these compounds are directly proportional to urine flow 
rate, urinary analyte concentration should be less dependent on urine output (Boeniger et al. 
1993; Barr et al. 2005).  We note that final model results for each analyte were nearly 
identical whether or not creatinine was included as a covariate; the inclusion of creatinine 
reduced random sources of variation and had little effect on coefficient estimates for other 
covariates. 
After adjusting for urinary creatinine, we were able to estimate elimination rate 
constants for each analyte, by including a fixed effect for time in our models.  We first 
examined work-task-specific elimination rates by including ‘time × task’ interaction term in 
each model.  Results showed that each model fit the data well using a single elimination rate 
constant, suggesting that analytes were eliminated at the same rate regardless of the work 
task.  The estimated T1/2 values were approximately 8 h for U-Phe, 10 h for U-Nap, 13 h for 
OH-Phe and OH-Pyr, and 26 hours for OH-Nap.  Literature reported estimates of the first-
order elimination half-time for OH-Pyr range from 4 - 48 h (Jacob and Seidel 2002; Brandt 
and Watson 2003; Hansen et al. 2008), thus, the estimated half-time of OH-Pyr in this study 
population is within the range of previous estimates.  Additionally, we observed that among 
workers exposed to hot asphalt, the half-time of OH-Phe is very similar to that of OH-Pyr, 
and the respective half-times of U-Nap and U-Phe are shorter than that of OH-Pyr.  We note 
that, while the model estimate for OH-Nap indicates a half-time of approximately 26 h, this 
value may be overestimated due to the highly significant smoking effect. 
Considering the estimated half-times, we incorporated a fixed effect for ‘workday’ 
into our models to investigate bioaccumulation effects from previous workdays.  No workday 
effects were observed for U-Phe, which had the shortest estimated biological half-time, or for 
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OH-Nap, which was highly affected by smoking status.  However, a significant workday 
effect was observed for U-Nap, OH-Phe, and OH-Pyr.  For each analyte, levels were lowest 
on the first day of the workweek and increased over workdays two and three.  While the 
estimated half-times and significant workday effects indicated a contribution to analyte levels 
from previous workdays, these contributions were relatively modest in relation to that of 
exposure on the current day (see Figure 4.2.).   
After adjusting for time and workday effects, a significant work task effect was 
observed for U-Nap, U-Phe, OH-Phe, and OH-Pyr.  Results from the linear mixed-effects 
models suggest that analyte levels in roller operators were significantly lower than in pavers 
performing other work tasks.  In fact, when roller operators were removed from the models, 
no significant effects were observed across paver operators, screedmen, and rakers.  Prior 
assessments of this study population showed that the rank order of PAH exposures across 
work tasks varied according to the exposure type (air measurement or dermal patch), and, in 
the case of dermal patches, the particular exposure surrogate (total dermal PAHs vs. dermal 
Pyr) (McClean et al. 2004a; McClean et al. 2004b).  However, roller operators were shown to 
have experienced both the lowest air levels (measured by both total airborne PAHs and 
airborne Pyr) and lowest dermal-patch levels (measured by both total dermal PAHs and 
dermal Pyr) when compared to paver operators, screedmen, and rakers.  Since results of our 
urinary biomarkers follow the same patterns, we have evidence that U-Nap, U-Phe, OH-Nap, 
and OH-Pyr may all be good surrogates for occupational exposure to PAHs in jobs 
employing asphalt.   
Results from the final model for OH-Nap indicate that smoking status had a highly 
significant effect on analyte levels.  This smoking effect probably explains the lower 
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correlation coefficients for OH-Nap compared to the other analytes (see Figure 4.1.).  
Furthermore, after adjusting for the smoking effect, no significant effect of work task was 
observed for OH-Nap in contrast to the other urinary biomarkers in our study (i.e., U-Nap, U-
Phe, OH-Phe, and OH-Pyr).  This effect of smoking reduces the utility of OH-Nap as a 
measure of total-PAH exposure among asphalt workers compared to the other urinary 
biomarkers measured in our study.   
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5.         Paper IV.  Biomarkers of Naphthalene, Phenanthrene, and Pyrene are 
Predictors of Particulate Exposures to Polycyclic Aromatic Compounds in Asphalt-
Exposed Workers [Sobus, J.R., McClean, M.D., Herrick, R.F., Waidyanatha, S., 
Nylander-French, L., Kupper, L.L., Rappaport, S.M., to be submitted to Annals of 
Occupational Hygiene] 
  
5.1. Abstract 
During road paving, workers are exposed to gaseous and particulate constituents of 
asphalt, the latter containing numerous carcinogenic polycyclic aromatic hydrocarbons 
(PAHs).  Urinary PAH analytes have been independently validated as biomarkers of asphalt 
exposure in many studies.  Specifically, levels of urinary naphthalene (U-Nap) and 
hydroxynaphthalene (OH-Nap), urinary phenanthrene (U-Phe) and hydroxyphenanthrene 
(OH-Phe), and hydroxypyrene (OH-Pyr) have been associated with asphalt exposures.  Here, 
we compare these urinary analytes to determine the most suitable biomarker(s) of exposure 
to particulate asphalt emissions.  Our study included 20 paving workers whose exposures 
were measured repeatedly over three consecutive workdays.  Daily breathing-zone air and 
dermal patch measurements of 4-6 ring polycyclic aromatic compounds (PACs) were 
evaluated along with postshift, bedtime, and morning levels of U-Nap, U-Phe, OH-Nap, OH-
Phe, and OH-Pyr.  These data were used to model exposure-biomarker relationships while 
controlling for other covariates.  Overall, OH-Phe was identified as the most promising 
biomarker of asphalt exposure because air and dermal patch measurements of PACs were 
significant determinants of OH-Phe in postshift, bedtime, and morning urine samples (the 
only measured biomarker to show these effects at bedtime and the following morning).  For 
U-Nap, U-Phe, and OH-Pyr, both air and dermal patch 
measurements of PACs were also significant determinants of the respective levels in postshift 
urine, and dermal patch measurements were significant predictors of the levels in bedtime 
urine (all-three analytes) and morning urine (U-Nap and OH-Pyr only).  While a significant 
effect of creatinine concentration was observed for each of these analytes, modest effects of 
smoking status and BMI were also observed for U-Phe and OH-Pyr, respectively.  Levels of 
OH-Nap were not associated with PAC measurements in air or dermal patch samples but 
were significantly affected by smoking status, age, day of sample collection, and urinary 
creatinine concentration.  We conclude that OH-Phe, U-Nap, U-Phe, and OH-Pyr can be used 
as biomarkers of exposure to particulate asphalt emissions, with OH-Phe being the most 
promising biomarker.  Indications that levels of U-Nap, U-Phe, and OH-Pyr were 
significantly associated with dermal patch measurements well into the evening after a given 
work shift, combined with the small ratios of within-person variance to between-person 
variance at bedtime, suggest that bedtime measurements may be useful for investigating 
dermal PAH exposures. 
 
5.2. Introduction 
Asphalt (also known as bitumen) is a highly viscous petroleum product that is 
commonly used as a binding agent in the road-paving industry.  While the chemical 
composition of asphalt varies according to the source of petroleum and other ingredients used 
in the manufacturing process, constituents of asphalt include a complex assortment of 
hydrocarbons (NIOSH 2000).  Of the chemicals identified in asphalt emissions, attention has 
focused primarily upon the polycyclic aromatic hydrocarbons (PAHs), a group of fused-ring 
aromatic compounds, which includes several carcinogenic forms (IARC 1987).  During the 
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application of hot-mix asphalt, workers are exposed to PAHs in both the vapor phase 
(primarily 2-ring and 3-ring compounds) and the particulate phase (primarily 4-ring to 6-ring 
compounds).  Asphalt contains varying amounts of PAHs, depending upon the source of raw 
materials and whether coal tar was used in its production (Burstyn and Kromhout 2000; 
Burstyn et al. 2000; Burstyn et al. 2002).   Because the particulate emissions from asphalt 
contain the most carcinogenic PAHs, health investigators are particularly concerned about 
asphalt workers’ exposures to particulate matter via inhalation and dermal contact.   
Although epidemiological studies point to increased cancer risks among asphalt 
workers (Partanen and Boffetta 1994; Hooiveld et al. 2002; Burstyn et al. 2003; Randem et 
al. 2004; Boffetta et al. 1997) that are likely related to PAH exposures, the quantitative 
relationship between exposures to asphalt chemicals and cancer risk is uncertain (Chiazze et 
al. 1991; NIOSH 2000).  This uncertainty stems largely from difficulties in assessing 
exposures to asphalt emissions, particularly the PAH content, via mixed routes (i.e., air and 
dermal contact, as well as ingestion) and physical forms (i.e., vapors and particulate matter).   
Several previous investigations have quantified asphalt exposures in both air samples 
and dermal patches to gauge the amounts of PAHs potentially inhaled and deposited on the 
skin (Jongeneelen et al. 1988; McClean et al. 2004a; Vaananen et al. 2005).  Analytes have 
included specific PAH compounds as well as several nonspecific measures of PAH exposure, 
including particulate matter (PM), benzene-soluble PM, and polycyclic aromatic compounds 
(PACs, a group of aromatic hydrocarbons containing primarily PAHs and heterocyclic 
compounds with 4 or more rings).  Urinary biomarkers have also been used to assess 
exposures and internal doses of PAHs in asphalt-exposed workers.  Urinary levels of 
unmetabolized PAHs in urine and of hydroxylated PAH metabolites, notably those of 
 74
naphthalene (Nap), phenanthrene (Phe), and pyrene (Pyr), have been associated with airborne 
and dermal exposures to PAHs in asphalt-exposed populations (Vaananen et al. 2003; 
McClean et al. 2004b; Campo et al. 2006a; Campo et al. 2006b; Vaananen et al. 2006; 
Buratti et al. 2007; Campo et al. 2007).  However, only a few studies have been published 
which reported concentrations of multiple urinary PAH biomarkers and the corresponding 
levels of PAHs or PACs in air and on the skin (Vaananen et al. 2005; Vaananen et al. 2006). 
In a study involving 20 road-paving workers who worked with hot-mix asphalt, PACs 
were measured in air samples and on dermal patches (McClean et al. 2004a).  Levels of the 
PACs varied significantly according to the specific tasks performed by the pavers, and also 
differed between air measurements and dermal patch measurements, suggesting that 
exposures of PACs were differentially expressed regarding the air and skin (McClean et al. 
2004a).  Recently, urinary levels of Nap and Phe and hydroxylated metabolites of Nap, Phe, 
and Pyr were measured in archived urine from the same 20 road pavers (see Chapter 4).  
Results showed that urinary biomarker measurements significantly varied by task, as had 
been observed for PAC measurements in the same workers (see Chapter 4).  The purpose of 
the current investigation was to statistically model the relationships between levels of urinary 
PAH analytes and the corresponding PAC measurements in air and dermal patch samples 
from these same 20 asphalt-exposed workers.  This analysis further delineates the differences 
between air samples and dermal patch samples as measures of exposure to PAHs and points 
to particular urinary PAH analytes that may be useful biomarkers of exposure to PAHs 
among asphalt-exposed workers.  These results should be useful in the design of future 
studies to assess exposures to PAHs in asphalt emissions for both hazard control and 
epidemiological investigations.   
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5.3. Methods 
5.3.1. Subjects and air and urine measurements 
Twenty male road-paving workers, all residing in the Greater Boston area of the U.S., 
were included in the study.  Workers were recruited with informed consent according to a 
protocol reviewed for the protection of human subjects at Harvard University.  Information 
about smoking habits and body size were obtained by questionnaire. 
Starting at the beginning of the workweek, daily air measurements and dermal patch 
measurements were collected from each worker over three consecutive days.  Personal air 
measurements of PACs were collected according to NIOSH Method 5506 (NIOSH 1998b), 
using a personal sampling pump operating at 2 l/min to draw air through a Teflon filter (for 
particulate-phase PACs, hereafter ‘P-PACs’) followed by a XAD-2 sorbent tube (for vapor-
phase PACs).  Levels of PACs on dermal patch samples (D-PACs) were measured using a 
method described by Jongeneelen et al. (Jongeneelen et al. 1988) and Van Rooij et al. 
(VanRooij et al. 1993), with minor modifications.  A soft polypropylene filter was attached to 
an exposure pad to create a dermal patch with an effective surface area of 8.71 cm2.  Using an 
adhesive backing, the dermal patch was attached to the underside of each wrist (the average 
of the left and right wrist measurements were used in this study).  Levels of PACs in air and 
dermal patch samples were analyzed using liquid extraction coupled with high-pressure 
liquid chromatography as described previously (McClean et al. 2004a; McClean et al. 
2004b). 
Urine samples were collected from all workers before work (morning), after work 
(postshift), and at bedtime of each workday.  Morning samples collected on the first day of 
the workweek (after a work-free weekend) were treated as baseline samples for each subject.  
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Each morning sample, collected on a subsequent workday, was treated as the final 
observation from the previous workday.  All urine samples were collected in sterilized 
polypropylene containers and stored at -20˚C for up to seven years prior to analysis.  Levels 
of urinary Nap and Phe (U-Nap and U-Phe, respectively) were determined using head space-
solid phase microextraction coupled with gas chromatography-mass spectrometry (see 
Chapter 3, section 3.3.3.), and levels of OH-Nap, OH-Phe, and OH-Pyr were determined 
using solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry 
as briefly summarized in the companion to this paper (see Chapter 4, section 4.3.3.).  We note 
that ‘OH-Nap’ is defined here as the sum of 1- and 2-hydroxynaphthalene, ‘OH-Phe’ is the 
sum of 2-, 3-, 4-, and 9-hydroxyphenanthrene, and ‘OH-Pyr’ is 1-hydroxypyrene.  
Descriptive statistics of the levels of U-Nap, U-Phe, OH-Nap, OH-Phe and OH-Pyr are 
described in a companion paper (see Chapter 4).  Creatinine levels were determined using a 
colorimetric procedure (Procedure No. 555, Sigma Diagnostics, Dorset, U.K.) (Sigma 
Chemical Co. 1984).     
 
5.3.2. Statistical analyses 
In preliminary analyses, levels of PACs in particulate-phase and vapor-phase samples 
were found to be highly correlated.  Thus, to remove problems related to collinearity in 
statistical models, and for ease of interpretation, we used only airborne particulate 
measurements (i.e., P-PACs) along with dermal PAC measurements (i.e., D-PACs) in 
statistical analyses.  This approach also had the advantage of focusing upon the larger (4-ring 
to 6-ring) carcinogenic PAHs that were common to both air samples (P-PACs) and dermal 
patch samples (D-PACs).  (Very similar results were obtained when vapor-phase PACs were 
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used instead of P-PACs in statistical models).  The level of creatinine measured in each urine 
specimen (CREATININE) was included in the models as an independent variable to allow for 
adjustments on covariates as well as the dependent variables (Barr et al. 2005). 
 All statistical tests were performed using SAS statistical software (v. 9.1, SAS 
Institute, Cary, NC).  All levels of air, dermal patch, and urinary analytes were evaluated 
after natural-log transformation to satisfy normality assumptions and to remove 
heteroscedasticity.  Considering the repeated measures study design, data were evaluated 
using linear mixed-effects models (Proc MIXED).  Correlation coefficients for exposure data 
were determined according to Hamlett et al. (Hamlett et al. 2003).  Postshift, bedtime, and 
morning urinary analyte data were individually regressed on their respective workday 
exposures, along with covariates.  Baseline urinary analyte data were not included in this 
statistical analysis, but were described in a companion paper (see Chapter 4).  The following 
numbers of observations were available for the different sampling times: U-Nap and U-Phe 
models included 51 postshift, 50 bedtime, 48 morning measurements while OH-Nap, OH-
Phe, and OH-Pyr models included 49 postshift, 48 bedtime, and 46 morning measurements.   
For dermal patch samples, McClean et al. defined the limit of quantitation (LOQ) as 
three times the standard deviation of field-blank values (McClean et al. 2004a).  Using this 
criterion, approximately 30% of dermal patch measurements used in this analysis were below 
the LOQ.  However, because values were reported for these observations, we used the 
reported levels in our analyses and did not impute values below the LOQ. 
 The full mixed model for an exposure-biomarker relationship at the hth sampling time 
(i.e., postshift = 1, bedtime = 2, and morning = 3) is defined as: 
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Yhij = ln(Xhij) = β0h + β1CREATININEhij + β2P-PACshij + β3D-PACshij + β4DAYhij +  
β5HOURhij + β6AGEi + β7BMIi + β8SMOKEi + bhi + εhij      (1) 
   
for j = 1, 2, ..., nhi  measurements of the ith individual at the hth sampling time; 
for i = 1, 2, ..., 20 individuals; 
for h = 1, 2, or 3;  
 
where Xhij represents the analyte concentration for the jth measurement of the ith individual 
and Yhij is the natural logarithm of the individual measurement Xhij.  The coefficient β0h 
represents the intercept for the hth sampling time.  The coefficients β1 - β8 represent the 
coefficients for fixed effects, which include CREATININEhij [creatinine concentration (g/l) 
for the jth measurement of the ith individual at the hth sampling time], P-PACshij (ng/m3) and 
D-PACshij (ng/cm2) which correspond to the jth air and dermal patch measurements, 
respectively, for the ith individual at the hth sampling time, DAYhij and HOURhij (hour: 
postshift = 0 h; bedtime and morning values equal elapsed hours since postshift sample) for 
the jth measurement of the ith individual at the hth sampling time, and AGEi, BMIi, and 
SMOKEi which represent the ith subject’s age (y), body mass index (kg/m2), and smoking 
status (nonsmoker = 0), respectively.   
In Model 1, bhi represents the random effect for the ith individual at the hth sampling 
time and εhij represents the random error for the jth measurement of the ith individual at the 
hth sampling time.  It is assumed that bhi and εhij are normally distributed with means of zero 
and variances of σ 2
hbY
 and σ 2
hwY
, representing the between-person and within-person 
components of total variance (i.e., σ 2
hbY
+σ 2
hwY
= σ 2
hY
), respectively, for sampling time h.  
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Linear mixed-effects models were constructed using restricted maximum likelihood 
estimates (REML) of variance components.  Fixed effects were maintained in the models at a 
significance level of α = 0.10, using manual backwards stepwise elimination.  Bayesian 
Information Criterion (BIC) values were used to select between competing models.  
Compound symmetry covariance matrices were used; these generally yielded the lowest BIC 
diagnostic values compared to those yielded by other tested matrices (homogeneous 
autoregressive, heterogeneous autoregressive). Observations with missing values (i.e., air or 
dermal patch measurement, urinary analyte measurement, significant covariate) were not 
included in the final models.      
Linear mixed-effects models including only  β0h, bhi, and εhij were also constructed for 
each urinary analyte.  The estimate of σ 2
hY
from each null model (no additional fixed effects), 
designated , was used along with the estimate of 2 nullˆ hYσ σ 2hY from each full model (including 
significant fixed effects), designated , to calculate the percent of the variance explained 
by fixed effects, where: [( - )/ ] × 100 = % explained. 
2
fullˆ hYσ
2
nullˆ hYσ 2 fullˆ hYσ 2 nullˆ hYσ
 
5.4. Results 
5.4.1. Postshift urine samples 
Table 5.1. shows the final models for analytes in postshift samples.  Levels of P-
PACs, D-PACs, and CREATININE were significant predictors of levels of U-Nap, U-Phe, 
OH-Phe, and OH-Pyr and BMI was a significant predictor OH-Pyr.  The levels of P-PACs, 
D-PACs, and CREATININE collectively explained 66%, 54%, 42%, and 41% of the 
variability in levels of OH-Phe, U-Nap, U-Phe, and OH-Pyr, respectively.  When 
CREATININE was removed from the models, P-PACs and D-PACs explained 53%, 47%, 
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37%, and 35% of the variability in levels of OH-Phe, U-Nap, U-Phe, and OH-Pyr, 
respectively.  Conversely, when P-PACs and D-PACs were removed from the models, 
CREATININE explained 13%, 8%, 6%, and 5% of the variability in levels of OH-Phe, U-
Nap, U-Phe, and OH-Pyr, respectively.  This indicates much weaker effects of CREATININE 
on analyte levels than those of air and dermal patch measurements, i.e., P-PACs and D-
PACs, respectively.  After adjusting for CREATININE, P-PACs, and D-PACs, a significant 
effect of BMI was observed on levels of OH-Pyr only.  The negative regression coefficient 
suggests that OH-Pyr levels were lower in individuals with higher BMIs.  Interestingly, the 
model for OH-Nap levels was quite different from those for all the other analytes in postshift 
urine.  For OH-Nap, P-PACs and D-PACs were not significant predictors and the final model 
included only CREATININE, DAY, AGE, and SMOKE.  Together, these variables explained 
74% of the postshift variability in OH-Nap levels.   
Table 5.1. shows, for each analyte, the estimated between-person and within-person 
variance components, designated 2ˆ
hbY
σ  and 2ˆ
hwY
σ , respectively, along with corresponding 
values of λˆ , representing the ratio of the within-person variance component to the between-
person variance component (i.e., λˆ  = 2ˆ
hwY
σ / 2ˆ
hbY
σ ).  For U-Phe, 2ˆ
hbY
σ = 0 indicating that all of the 
variation in this biomarker between persons was explained by P-PACs, D-PACs, and 
CREATININE.  For U-Nap and OH-Pyr, after adjusting for significant fixed effects, there 
was a greater estimated within-person variance component ( 2ˆ
hwY
σ ) than estimated between-
person variance component ( 2ˆ
hbY
σ ), as shown by λˆ  values of 2.23 and 1.29, respectively.  
Values of 2ˆ
hbY
σ and 2ˆ
hwY
σ  were similar for OH-Phe ( λˆ  = 0.881), whereas 2ˆ
hwY
σ  was 
considerably smaller than 2ˆ
hbY
σ  for OH-Nap ( λˆ  = 0.483). 
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5.4.2. Bedtime urine samples 
Table 5.2. shows the final models for analytes in bedtime samples.  In these samples, 
OH-Phe was the only analyte to be significantly affected by the exposure variables, P-PACs 
and D-PACs, as well as CREATININE.  These combined effects explained 56% of OH-Phe 
variability.  When CREATININE was considered as the only fixed effect, it explained 22% of 
the variability in OH-Phe levels.  When P-PACs and D-PACs were considered as predictors 
of OH-Phe without CREATININE, they explained 23% of OH-Phe variability.  Thus, in 
bedtime samples, the exposure variables and CREATININE contributed equally to the levels 
of OH-Phe.  No other covariates were significant determinants of OH-Phe levels.   
As with OH-Nap levels in postshift samples, OH-Nap levels in bedtime samples were 
highly affected by CREATININE and SMOKE (explaining 65% of the variability in OH-Nap) 
but were not affected by exposure levels (i.e., P-PACs and D-PACs).  For OH-Pyr, U-Nap, 
and U-Phe, significant effects of CREATININE and D-PACs on analyte levels were observed, 
together explaining 50%, 30%, and 30% of the respective analyte variability.  When included 
in the models without other fixed effects, CREATININE explained 25%, 15%, and 14% of 
the variability in OH-Pyr, U-Phe, and U-Nap levels, respectively.  When CREATININE was 
removed from each model, D-PACs explained 15%, 12%, and 11% of the variability in OH-
Pyr, U-Nap, and U-Phe levels, respectively.  After adjusting for D-PACs and CREATININE, 
a moderately significant effect of SMOKE on U-Phe was observed.  When included in the 
model, the combined effects of CREATININE, D-PACs, and SMOKE explained 36% of 
variability in U-Phe levels. 
Results from the final models showed that all analytes except U-Phe ( λˆ  = 1.13) had 
λˆ  values less than one (U-Nap = 0.528; OH-Nap = 0.698; OH-Phe = 0.604; OH-Pyr = 0.483) 
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indicating greater between-person variability compared to within-person variability at 
bedtime. 
 
5.4.3. Morning urine samples 
Model results for morning samples are shown in Table 5.3.  In these samples, only the 
levels of OH-Phe were significantly affected by both air and dermal patch levels, i.e., P-
PACs, and D-PACs, as well as CREATININE; together, these three variables explained 65% 
of the variability in morning OH-Phe levels.  CREATININE alone explained 38% of the 
variability in OH-Phe levels while P-PACs and D-PACs jointly explained 25% of OH-Phe 
variability.   
For U-Nap and OH-Pyr, D-PACs (but not P-PACs) and CREATININE were 
significantly associated with analyte levels, together explaining 36% and 35% of the 
variability in OH-Pyr and U-Nap levels, respectively.  When D-PACs was removed from the 
models, CREATININE alone explained 20% and 28% of the variability in OH-Pyr and U-Nap 
levels, respectively.  When D-PACs was solely considered, 7% and 1% of the variability in 
OH-Pyr and U-Nap levels was explained, respectively.  After adjusting for CREATININE and 
D-PACs, a significant negative BMI effect was observed for OH-Pyr.  In total, the effects of 
CREATININE, D-PACs, and BMI explained 46% of the variability in OH-Pyr levels.  Air and 
dermal patch measurements from the previous workday (i.e., P-PACs and D-PACs) were not 
significant determinants for either OH-Nap or U-Phe.  In fact, CREATININE and DAY were 
the only significant determinants for U-Phe, explaining 33% of the variability, and 
CREATININE, DAY, and SMOKE were the only significant determinants for OH-Nap, 
together explaining 61% of the variability.   
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In morning urine samples, more variability in OH-Pyr levels was observed between 
subjects than was observed within subjects ( λˆ  = 0.744).  Estimates of λ were close to one for 
U-Nap and OH-Phe ( λˆ  = 1.06 and 0.961, respectively) and were greater than one for U-Phe 
and OH-Nap ( λˆ  = 3.31 and 2.60, respectively).  This indicates comparatively larger within-
person variability for U-Phe and OH-Nap in morning urine samples. 
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Table 5.1. Results from linear mixed-effects models evaluating postshift urinary analyte levels.  
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Parameters   Estimate   (SE)   p- value   Estimate   (SE)   p- value   Estimate   (SE)   p- value   Estimate   (SE)   p- value   Estimate   (SE)   p- value
Fixed effects
Intercept    0.969    (0.536)    0.09    0.472    (0.674)    0.5    10.4      (0.489) < 0.0001    5.25      (0.418) < 0.0001    6.09       (1.15) < 0.0001
CREATININE a    0.446    (0.158)    0.009    0.476    (0.204)    0.03    0.519    (0.112) < 0.0001    0.490    (0.121)    0.0004    0.348    (0.198)    0.09
P-PACs b    0.235    (0.067)    0.002    0.234    (0.085)    0.01    NS    0.245    (0.051) < 0.0001    0.258    (0.082)    0.004
D-PACs c    0.202    (0.053)    0.0008   0.255    (0.066)   0.0007   NS    0.215    (0.041) < 0.0001   0.223    (0.066)   0.002
DAY    NS    NS    0.159    (0.051)    0.005    NS    NS
BMI    NS    NS    NS    NS   -0.072    (0.029)    0.02
AGE    NS   NS  -0.016    (0.008)   0.05   NS   NS
SMOKE    NS    NS < 0.0001    NS    NS
      no   -1.59      (0.221)
      yes    0            (ref.)
Random effects
σ 2 B     0.090    0    0.143    0.101    0.197
σ 2 w    0.201    0.514    0.069    0.089    0.254
λ    2.23    NA    0.483    0.881    1.29
  OH-Pyr  U-Nap   U-Phe   OH-Nap   OH-Phe
a creatinine concentration (g/l) 
b air concentration of particulate PAC [ln(ng/m3)] 
c dermal patch concentration of particulate PAC [ln(ng/cm2)] 
σ2B = between-subject variance component 
σ2w = within-subject variance component 
λ = variance ratio (σ2w/ σ2b) 
 Table 5.2. Results from linear mixed-effects models evaluating bedtime urinary analyte levels. 
Parameters   Estimate   (SE)   p- value   Estimate   (SE)   p- value    Estimate   (SE)   p- value    Estimate   (SE)   p- value    Estimate   (SE)   p- value
Fixed effects
Intercept    2.23      (0.442) < 0.0001    1.46      (0.658)    0.04    9.48      (0.355) < 0.0001    5.13      (0.603) < 0.0001    4.04      (0.568) < 0.0001
CREATININE a    0.499    (0.161)    0.004    0.766    (0.234)    0.003    0.720    (0.148) < 0.0001    0.795    (0.144) < 0.0001    0.942    (0.205) < 0.0001
P-PACs b    NS    NS    NS    0.141    (0.066)    0.04    NS
D-PACs c    0.203    (0.067)    0.005    0.320    (0.097)    0.003    NS    0.213    (0.062)    0.002    0.339    (0.085)    0.0005
DAY    NS    NS    NS    NS    NS
HOURS    NS   NS   NS   NS   NS
BMI    NS    NS    NS    NS    NS
AGE    NS    NS    NS    NS    NS
SMOKE    NS    0.07    NS    NS
      no   -0.819    (0.432)   -1.57      (0.299) < 0.0001
      yes    0            (ref.)    0            (ref.)
Random effects
σ 2 B     0.352    0.452    0.255    0.255    0.603
σ 2 w    0.186     0.509    0.178    0.154    0.291
λ    0.528    1.13    0.698    0.604    0.483
  OH-Pyr  U-Nap   U-Phe   OH-Nap   OH-Phe
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a creatinine concentration (g/l) 
b air concentration of particulate PAC [ln(ng/m3)] 
c dermal patch concentration of particulate PAC [ln(ng/cm2)] 
σ2B = between-subject variance component 
σ2w = within-subject variance component 
λ = variance ratio (σ2w/ σ2b) 
 
Table 5.3. Results from linear mixed-effects models evaluating morning urinary analyte levels. 
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ters   Estimate   (SE)   p- value   Estimate   (SE)   p- value   Estimate   (SE)   p- value   Estimate   (SE)   p- value   Estimate   (SE)   p- value
Fixe fects
 
e
 d ef
Param
Intercept    2.03      (0.382) < 0.0001    0.731    (0.480)    0.1    8.76      (0.421) < 0.0001    4.92      (0.419) < 0.0001    6.97      (1.41)    0.0001
CREATININE a    0.705    (0.142) < 0.0001    0.917    (0.216)    0.0002    0.755    (0.151) < 0.0001    0.647    (0.105) < 0.0001    0.719    (0.209)    0.002
P-PACs b    NS    NS    NS    0.184    (0.052)    0.002    NS
D-PACs c    0.146    (0.059)    0.02    NS    NS    0.135    (0.044)    0.005    0.322    (0.078)    0.0004
DAY    NS    0.318    (0.167)    0.07    0.246    (0.112)    0.04    NS    NS
HOURS    NS    NS    NS    NS    NS
BMI    NS    NS    NS    NS   -0.094    (0.041)    0.03
AGE    NS    NS    NS    NS    NS
SMOKE    NS    NS   -1.24     (0.291)    0.0003    NS    NS
      no    0           (ref.)
      yes
Random effects
σ 2 B     0.202    0.241    0.126    0.103    0.434
σ 2 w    0.214    0.798    0.328    0.099    0.323
λ d    1.06    3.31    2.60    0.961    0.744
  OH-Pyr  U-Nap   U-Phe   OH-Nap   OH-Phe
a creatinine concentration (g/l) 
b air concentration of particulate PAC [ln(ng/m3)] 
c dermal patch concentration of particulate PAC [ln(ng/cm2)] 
σ2B = between-subject variance component 
σ2w = within-subject variance component 
λ = variance ratio (σ2w/ σ2b) 
 5.5. Discussion 
In a previous investigation of 26 highway construction workers, 20 asphalt-exposed 
paving workers (the same 20 workers included in this study) were shown to have higher 
levels of urinary OH-Pyr in postshift, bedtime, and morning samples when compared to 6 
milling workers who did not work with hot-mix asphalt (McClean et al. 2004b).  In a 
companion paper (see Chapter 4), we reanalyzed archived urine specimens from the same 20 
paving workers for several PAH biomarkers, namely, unmetabolized Nap and Phe, and the 
metabolites, OH-Nap, OH-Phe, as well as OH-Pyr [levels of OH-Pyr measured in the 
reanalyzed samples were highly correlated with the original OH-Pyr measurements (r = 0.89, 
p < 0.0001) indicating good agreement between studies] (McClean et al. 2004b).  We used 
these data to assess correlations between analytes, to determine biological half-times, and to 
assess task-based differences in analyte levels, while controlling for covariates (see Chapter 
4).  In this study, our major goal was to determine the effect of airborne particulate and 
dermal patch measurements (i.e., P-PACs and D-PACs, respectively) on these urinary 
analytes and to identify the most promising biomarkers of exposure to particulate-phase 
PAHs for asphalt-exposed workers and the best timing of specimen collection (postshift, 
bedtime, or morning).   
Figure 5.1. shows the percentages of urinary analyte variance explained by the sum of 
P-PACs and D-PACs in postshift, bedtime, and morning samples.  The sum of P-PACs and 
D-PACs explained much more of the variability of biomarker levels in postshift urine 
samples (up to 53%), compared to bedtime (up to 23%) and morning (up to 25%) samples.  
In postshift samples, the strongest association with exposure measurements (P-PACs plus D-
PACs) was observed for OH-Phe (53% of explained variance) followed by U-Nap (47%), U-
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 Phe (37%), and OH-Pyr (35%).  It is important to note that both P-PACs and D-PACs were 
each strongly associated with these urinary PAH analytes (see Table 5.1.) and, because the 
levels of P-PACs and D-PACs were essentially uncorrelated (r < 0.3), that air and dermal 
patch measurements appear to have contributed independently to the levels of the 
biomarkers.  The fact that these PAH biomarkers were more highly associated with exposure 
variables in postshift urine samples, compared to bedtime and morning samples, indicates 
that Nap, Phe, and Pyr were rapidly absorbed and eliminated from the body during and 
immediately following the work shift (Rappaport 2008).  Indeed, we estimated the biological 
half-times of these PAH biomarkers to range between 8 and 26 h (see Chapter 4). 
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 Figure 5.1. Percentage of urinary analyte variance explained  
by air and dermal patch concentrations of asphalt emissions.  
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 In bedtime and morning urine samples, P-PACs and D-PACs were much weaker 
predictors of urinary biomarker levels than they were in the postshift urine samples.  
Nonetheless, levels of OH-Phe were associated with both P-PACs and D-PACs in bedtime 
and morning samples, while those of U-Nap and OH-Pyr were significantly associated with 
levels of D-PACs (but not P-PACs) in bedtime and morning samples, and those of U-Phe 
were associated with D-PACs in bedtime (but not morning) samples (Tables 5.2. and 5.3.).  
The consistent influence of D-PACs on levels of PAH biomarkers in bedtime-urine and 
morning-urine samples suggests that dermal contact with Nap, Phe, and Pyr persisted well 
into the evening after a given work shift.  This finding is consistent with those of McClean et 
al. (McClean et al. 2004b) who used a distributed-lag model to investigate the influence of 
Pyr levels in air and dermal patches on levels of urinary OH-Pyr in these same 20 subjects.  
Based upon their modeling results, the authors concluded that the effect of the dermal patch 
Pyr levels on urinary OH-Pyr was approximately eight times that of the air Pyr levels.  
Moreover, the effect of inhalation exposure was determined to be more apparent immediately 
after the work shift (within 8 h), while the effect of dermal patch levels was more apparent 
during the period of 8 to 16 h after the work shift (McClean et al. 2004b).  Results from our 
linear mixed-effects models are consistent with the earlier findings of McClean et al., and 
also suggest that levels of U-Nap, U-Phe, OH-Phe, as well as OH-Pyr are suitable biomarkers 
of both inhaled and dermal patch PAH levels emanating from asphalt.   
Since P-PACs, D-PACs, and the urinary biomarkers were measured over three 
consecutive days, we included a ‘workday’ effect into our models (i.e., WORKDAY) to test 
the possibility that biomarker levels accumulated over the workweek.  After adjusting for P-
PACs, D-PACs, and other significant covariates, no significant workday effects were 
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 observed for U-Nap, OH-Phe, or OH-Pyr.  A significant positive workday effect was 
observed for U-Phe in morning samples only.  While this indicates a linear increase in 
morning U-Phe levels, overall these results tend to rule out any strong effects towards 
accumulation of the measured biomarkers from day to day, and reinforce the notion that 
these urinary analytes reflect exposure primarily on the current day.  A significant positive 
workday effect was also observed for OH-Nap in postshift samples and morning samples.  
As exposure effects (i.e., P-PACs and D-PACs) were not included in the final linear mixed-
models due to a lack of significance (most likely due to the confounding effects of smoking), 
it is difficult to interpret the observed WORKDAY effect for OH-Nap.   
In addition to assessing workday effects, we also added into the models a fixed effect 
of time in h postshift (HOURS) because bedtime and morning sample collection times varied 
from day to day and from person to person.  The median collection time for bedtime samples 
was 6.00 h (range: 2.50 - 14.3 h) and the median collection time for morning samples was 
15.3 h (range: 11.8 - 19.1 h) (see Chapter 4).  Results from each model showed no significant 
effect of HOURS on analyte levels.  This indicates that, after making adjustments for 
exposure levels and other covariates, subtle variations in sampling times did not affect 
urinary analyte levels.  
Levels of urinary creatinine (CREATININE) were significant predictors of all urinary 
analytes.  The positive regression coefficient in each model (Tables 5.1., 5.2., and 5.3.) 
indicates increased analyte levels with increased creatinine levels.  Since the urinary 
concentration of creatinine increases with decreased urine volume, this finding indicates that 
urine volumes varied considerably within and between the road pavers under investigation.  
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 Figure 5.2. shows the percent of each analyte’s variance explained by urinary creatinine in 
 
urine collected postshift, at bedtime, and in the morning following exposure. 
verall, U-Nap and U-Phe were less affected by creatinine than OH-Nap and OH-Phe; this 
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Figure 5.2. Percentage of urinary analyte variance explained  
by urinary creatinine concentration.    
 
O
would be expected because unmetabolized organic compounds tend to enter urine via 
diffusion from blood rather than via glomerular filtration in the kidney, the latter mechanism 
being responsible for elimination of polar metabolites (Boeniger et al. 1993).  To further 
investigate creatinine variability, we constructed a mixed model with CREATININE as the 
response variable and the period of sample collection (i.e., dummy variables for postshift, 
bedtime, or morning) as the predictor variables.  Results showed a significant effect of the 
period of sample collection (p-value < 0.0001) on creatinine levels, with the highest levels 
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 observed in postshift samples (mean = 1.93 g/l), followed by bedtime samples (mean = 1.55 
g/l), and then morning samples (mean = 1.43 g/l).  These changes in urinary creatinine levels 
may reflect a diurnal excretion pattern (Boeniger et al. 1993) as well as the dehydration of 
workers during hot work shifts.  We note that the creatinine concentration was highest at the 
end of the workday as would be expected following outdoor work.   
In postshift, bedtime, and morning samples, smoking status (i.e., SMOKE) was a 
highly 
 
signific
significant determinant of OH-Nap levels.  However, smoking status was not, at any 
time, a significant determinant of U-Nap levels.  This result for U-Nap corroborates those 
from previous studies where smoking status had little effect on U-Nap levels, particularly in 
moderately-exposed to highly-exposed workers (Serdar et al. 2003a; Waidyanatha et al. 
2003).  The result for OH-Nap also supports those from previous studies where OH-Nap was 
shown to be significantly affected by smoking status (Serdar et al. 2003a; Serdar et al. 2004).  
Serdar et al. (Serdar et al. 2004) showed that, at low Nap exposure levels, smokers produced 
higher OH-Nap levels than nonsmokers and, at high Nap exposure levels, smokers produced 
lower OH-Nap levels than nonsmokers.  The authors suggested metabolic induction by 
cigarette smoke at low Nap exposure levels.  A similar mechanism may have influenced OH-
Nap levels in this study.  We also note a significant smoking effect on U-Phe levels in 
bedtime samples.  Considering the lack of a smoking effect on U-Phe levels in postshift 
samples, this effect seems to be relatively modest compared to that of P-PACs and D-PACs.  
As observed by McClean et al. (McClean et al. 2004b) in this population, we note a
ant negative BMI effect on OH-Pyr levels.  This observation may indicate increased 
storage of Pyr in adipose tissue with elevated exposures, thereby limiting the amount of Pyr 
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 in the systemic circulation that is available for metabolism.  BMI was not observed to 
significantly affect any other analyte after adjusting for other fixed effects. 
Tables 5.1. - 5.3. list estimated values of the within-subject and between-subject 
variance components (i.e., 2ˆ
hwY
σ and 2ˆ
hbY
σ , respectively) obtained from the mixed models of 
each urinary biomarker, as well as the corresponding estimated variance ratio λˆ  = 2ˆ
hwY
σ / 2ˆ
hbY
σ , 
in each case.  Lin et al. (Lin et al. 2005) used values of λˆ  to choose between air 
measurements and biomarker measurements in selecting the particular measure of exposure 
that should be the least biasing in estimating the slope of a log exposure-log disease linear 
relationship.  In the current study, we can use λˆ  values to choose among postshift, bedtime, 
and morning urine samples to find the minimally-biased biomarker of exposure for an 
epidemiological investigation.  Interestingly, λˆ  values for each of the biomarkers, save OH-
Nap (which was affected primarily by smoking), were minimal in bedtime urine samples (see 
Tables 5.1. - 5.3.).  Indeed, for U-Nap ( λˆ  = 0.53), OH-Phe ( λˆ  = 0.60), and OH-Pyr ( λˆ  = 
0.48), the variance ratios were in the range of 0.5, which were smaller than those for the 
same analytes in postshift urine samples where values of λˆ  = 2.2, 0.88, and 1.3, respectively.  
In light of the earlier discussion concerning the possibility that these biomarkers reflect 
continued effects of D-PACs, this finding opens the possibility that bedtime measurements of 
these biomarkers could be useful in investigating dermal PAH exposures.  This conjecture 
will require further experimental confirmation. 
Urinary OH-Pyr is a widely used PAH biomarker due to its reported associations with 
occupational exposures to PAHs (Jongeneelen 2001).  In this study, we observed significant 
associations between particle-phase PACs (as measured by P-PACs and D-PACs) and OH-
Pyr levels.  This result was expected because Pyr, a 4-ring PAH, is often abundant in 
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 measurements of PM from asphalt and combustion sources.  Somewhat more surprising were 
the significant associations between Nap and Phe biomarkers (namely U-Nap, U-Phe, and 
OH-Phe) and particulate PAC measurements.  Naphthalene, a 2-ring PAH, occurs almost 
exclusively in the gas phase, whereas Phe, a 3-ring PAH, is partitioned between the gas-
phase and the particle-phase.  Our results suggest that these abundant 2-ring and 3-ring PAHs 
may be very good surrogates for particulate exposures stemming from asphalt sources.  
Moreover, the results from our postshift models indicate stronger associations between levels 
of U-Nap, U-Phe, and OH-Phe and the particulate PAC levels in air and dermal patch 
samples than the corresponding associations for OH-Pyr.  We do not recommend use of OH-
Nap as a biomarker of exposure to particulate asphalt emissions, due to the apparent 
confounding by smoking. 
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6. Discussion and Conclusions 
 
6.1. Summary and conclusions 
 
The assessment of levels of PAH exposure has been challenged by the sheer number 
of individual PAH compounds, the distribution of species between gas- and particle-bound 
phases, and the presence of multiple routes of exposure.  The purpose of this investigation 
was to evaluate the individual vapor-phase PAH constitutents, Nap and Phe, as possible 
surrogates for total PAH exposure, using measurements of air samples, dermal patch 
samples, and urine samples from groups of workers.  
Diesel exhaust is a known source of occupational and ambient PAH exposure.  In a 
controlled chamber study, where 10 human volunteers were exposure to 100 µg/m3 of DE, 
we identified Nap and Phe as being both abundant in DE, and highly differentiated with 
respect to measurements of control samples (purified air).  Furthermore, Nap and Phe were 
significantly correlated with accepted measures of particulate exposures emanating from 
diesel sources.  That is, levels of Nap were highly correlated with levels of organic carbon 
and particle-bound PAHs, and levels of Phe were highly correlated with levels of total 
volatile+semivolatile PAHs.  These findings offer promise that Nap and Phe can be useful 
surrogates for PAHs and organic particulate emissions in studies of DE exposure. 
A previous study examined the relationship between air levels of Nap and total PAHs 
in several industries, namely creosote impregnation, coke production, aluminum production, 
and an iron foundry (Rappaport et al. 2004).  Air levels of Nap and total PAHs were found to 
be highly correlated in each of these industries.  Additionally, air concentrations of Nap were 
 found to be proportional to those of total PAHs.  Using the available data from these same 
studies, we analyzed the relationship between air levels of Phe and total PAHs.  Like Nap, air 
concentrations of Phe were found to be proportional to those of total PAHs.  Thus, we have 
demonstrated that air concentrations of Nap and Phe track those of total PAHs, regardless of 
the source and exposure level, and conclude that Nap and Phe are promising surrogates of 
total PAH exposure through airborne routes.  Interestingly, when we compared air 
concentrations of Nap and Phe, we found that the ratio of Nap/Phe decreased with increasing 
levels of airborne Phe, regardless of the source of PAH exposure, i.e., DE, asphalt emissions, 
or coke-oven emissions.  This suggests that the particular chemical processes that generate 
PAHs tend to produce increasingly more Phe relative to Nap as the overall amount of PAH 
production increases.   
Biomarkers offer a means to assess exposure to PAHs though multiple pathways, 
including inhalation, ingestion, and dermal contact.  Since small amounts of unmetabolized 
PAHs are eliminated in the urine following passive diffusion from the blood to the urine, the 
urine concentrations of PAHs are thought to reflect blood levels.  We measured levels of Nap 
and Phe in the urine of diesel-exposed workers, asphalt workers, and coke-oven workers, 
groups given a priori exposure designations of low, medium, and high, respectively.  Levels 
of urinary Nap and Phe followed the a priori exposure designations, and were highly 
correlated, suggesting a common source of exposure to Nap and Phe in each case.  
Additionally, as observed with air levels of Nap and Phe, the ratio of urinary Nap/Phe 
decreased with increasing levels of urinary Phe.  Therefore, we conclude that urinary levels 
of Nap and Phe likely reflect the corresponding airborne concentrations at the time of urine 
 97
 collection.  This suggests that urinary Nap and Phe are promising surrogates of occupational 
exposure to total PAHs. 
In a group of asphalt-exposed workers, we measured urinary levels of unmetabolized 
Nap and Phe (U-Nap and U-Phe, respectively), along with phenolic metabolites of Nap, Phe, 
and Pyr [hydroxynapthalenes (OH-Nap), hydroxyphenanthrenes (OH-Phe), and 
hydroxypyrene (OH-Pyr), respectively].  We observed significant correlations between each 
of these analytes, suggesting a common exposure source of Nap, Phe, and Pyr.  When we 
compared air and dermal patch measurements of particulate PAHs (or PACs) with urinary 
analyte levels, we observed significant associations between exposure levels (represented by 
air and dermal patch measurements) and biomarker levels.  Specifically, U-Nap, U-Phe, OH-
Phe, and OH-Pyr were strongly associated with both air and dermal patch measurements of 
particulate PAH emissions (OH-Nap was highly confounded by cigarette smoking).  
Therefore, we conclude that U-Nap, U-Phe, OH-Phe, and OH-Pyr can be useful surrogates of 
exposure to asphalt-derived PAHs via inhalation and dermal contact.  Furthermore, we 
determined that measurements of U-Nap, U-Phe, OH-Phe, and OH-Pyr in urine specimens 
collected at bedtime were good predictors of PAH levels on dermal patches, and had lower 
ratios of within-person variability to between-person variability.  This suggests that bedtime 
urine samples may be particularly useful for investigations of dermal PAH exposure in 
asphalt-exposed workers.   
 
6.2. Significance of this study 
The methods and results of this investigation should enhance our ability to assess 
PAH exposures, particularly those from derived from diesel and asphalt sources.  As 
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 previously mentioned, measures of particulate exposure, namely EC, OC, and PM2.5, have 
traditionally been used as surrogates for DE exposure, despite their inability to be linked with 
either the PAH content of diesel particulates or biomarkers of PAH exposure.  This has made 
it difficult to determine whether the mechanism by which DE may cause lung cancer is 
related to the PAH content of DE or to the particles per se.  Thus, by demonstrating that Nap 
and Phe are abundant in DE, are correlated with organic constituents of DE, and can be 
measured as biomarkers in human urine, we offer a means to link external exposure to 
internal PAH dose, a link that may help resolve this controversy.   
The assessment of the carcinogenic effects of asphalt emissions is also fraught with 
uncertainty, due to limited quantitative exposure data from air and dermal measurements and 
possible confounding by smoking and other factors.  Here, we have identified strong 
associations between biomarkers of Nap, Phe, and Pyr in asphalt workers and the 
corresponding air and dermal patch measurements of particulate PAHs.  Our work indicates 
that particular urinary PAH biomarkers, namely, U-Nap, U-Phe, OH-Phe, and OH-Pyr are all 
promising surrogates for exposures to total particulate PAHs in asphalt workers.  The fact 
that U-Nap, U-Phe, OH-Phe, and OH-Pyr were associated with dermal patch measurements 
of PAHs in bedtime urine points to the possibility that bedtime measurements have particular 
advantages in future epidemiological studies of asphalt-exposed persons.   
Urinary PAH metabolites (i.e., OH-Nap, OH-Phe, and OH-Pyr) are the products of 
phase-I and phase-II metabolism that can vary between individuals (and within individuals 
over time) due to differences in levels of exposure and other factors that affect the uptake of 
the contaminant (e.g., inhalation rate, presence of dermal exposure, and genetic differences).  
Pyrene is a widely used surrogate for PAH exposure because it is a 4-ring compound, and 
 99
 therefore, is representative of the particulate fraction of PAHs, containing the most 
carcinogenic compounds.  However, because Pyr does not contain a bay region and is 
metabolized by a more simple scheme than BaP and the other carcinogenic 4-6 ring PAHs, it 
may not be particularly useful as a measure of PAH metabolism and the associated risk of 
cancer.  To better understand PAH metabolism in vivo, we investigated the levels of urinary 
metabolites of the more abundant PAH, Phe, which does contain a bay region and undergoes 
essentially the same types of metabolism as the carcinogenic 4-6 ring PAHs.  Thus, it is 
noteworthy that we detected stronger associations between particulate PAHs and U-Phe and 
OH-Phe, when compared to the association between particulate PAHs and OH-Pyr.  This 
suggests that, in addition to being a better model for PAH metabolism, Phe is also at least as 
good a surrogate for particulate PAH exposure as Pyr. 
 
6.3. Strengths and weaknesses of this study 
The inability to discriminate DE from other exposure sources complicates the 
establishment of a causal association between DE exposure and lung cancer.  In the chamber 
study (Chapter 2), air used in control exposures was purified with HEPA filters and activated 
charcoal.  This reduced contamination through unknown sources of measured analytes.  DE 
was introduced into the chamber after a dilution with purified air to achieve a highly 
regulated, feedback-controlled level.  Considering these control measures, we were able to 
precisely quantify DE constituents without the influence of external sources, and were able to 
select candidate markers of exposure to DE particulates based on the differentiation of levels 
in DE with respect to purified air.  
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 Results of the chamber study showed significant daily variations in specific analyte 
levels (e.g., Nap), most likely due to daily variations in truck-engine performance.  While 
correlations were observed between selected analytes and other surrogate measures of DE, 
there existed very little dynamic range in exposure levels.  Controlled DE exposures at 
varying concentrations (e.g., 100 µg/m3, 200 µg/m3, and 300 µg/m3) would allow for a better 
assessment of the correlations between DE constituents.  Additionally, investigations of 
environmental and occupational DE exposure are warranted to further confirm that Nap and 
Phe are useful markers of DE exposure. 
In Chapter 3, urinary measurements of Nap and Phe were proposed as biomarkers of 
occupational PAH exposure.  A major strength of our analysis was the availability of a wide 
range of urinary analyte levels, i.e., 200-fold and 470-fold range of U-Nap and U-Phe levels, 
respectfully, due to our ability to use samples reflecting different types of occupational PAH 
exposures, namely diesel exhaust, asphalt emissions, and coke-oven emissions.  For diesel-
exposed workers and asphalt workers, pre-shift urine measurements were available, allowing 
each subject to act as his/her own control.  However, our study was limited by the lack of 
available pre-shift measurements for coke-oven workers and we had to rely upon factory 
controls, who were also highly exposed.  This introduced some uncertaintity into our analysis 
of adjusted Nap and Phe levels in our full models.  Finally, while measurements of air and 
urine suggested a decrease in the ratio of Nap/Phe with increasing Phe levels, these results 
are based on a limited amount of data, and require further confirmation in future studies. 
In the final study (Chapters 4 and 5), we were able to relate levels of urinary Nap, 
Phe, and Pyr analytes to air and dermal patch measurements of particle-bound PAHs.  A 
major strength of this study was the repeated-measures sampling design, which allowed us to 
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 assess biological half-times of urinary analytes, and the effect of repeated exposures over 
consecutive workdays.  Additionally, covariate information allowed us to assess the effects 
on analyte levels of urine dilution (as measured by creatinine concentration), BMI, age, and 
smoking status.  Although we had both air and dermal patch measurements for this analysis, 
little work has been done to validate patch sampling as a useful means of assessing PAH 
exposure through dermal routes.  Therefore, dermal patch concentrations could only be 
included in our statistical models as measures of dermal deposition of asphalt emissions, and 
not necessarily true measures of dermal exposure.  Also, the effect of particulate PAH 
exposure through ingestion was not considered in our models.  Accounting for ingestion 
exposure may explain some of the unresolved variance in urinary analyte levels. 
 
6.4. Suggestions for future research 
Because air measurements of Nap and Phe were identified as promising surrogates for 
DE exposure in our chamber study, and because U-Nap and U-Phe were identified as 
promising biomarkers of PAH exposure, we will examine urinary levels of Nap and Phe in 
the 10 volunteer participants of the controlled chamber study.  In addition, we will assess 
levels of Nap and Phe in samples of exhaled breath condensate and plasma, to better 
understand rates of uptake and elimination, and to validate additional Nap and Phe 
biomarkers.  Finally, we will determine levels of OH-Nap, OH-Phe, and OH-Pyr in the urine 
samples from the 10 volunteer participants of the chamber study.  We will pay particular 
attention to the effects of urine dilution on analyte concentrations given the low exposure 
levels of Nap, Phe, and Pyr in this study. 
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 In the study of 26 road-construction workers, we measured U-Nap and U-Phe, as well 
as phenolic metabolites of Nap and Phe, including 1- and 2-OHNap, and 2-, 3-, 4-, and 9-
OHPhe.  However, our statistical analyses only considered the sum of phenolic Nap and Phe 
metabolites (i.e., total OH-Nap and total OH-Phe, respectively).  In the future, we plan to 
develop linear mixed-effects models to assess the individual relationships between U-Nap 
and individual phenolic metabolites of Nap, and between U-Phe and individual phenolic 
metabolites of Phe.  This work will highlight the influence of exposure and covariates on the 
production of individual phenolic isomers.  Considering the observed effect of smoking 
status on OH-Nap levels, urinary cotinine concentration will be used to better explain the 
variability in OH-Nap levels.  Ultimately, statistical models will be used to associate 
unmetabolized PAHs in urine (as a measure of internal PAH dose) with additional urinary 
metabolites (i.e., dihydrodiols and tetraols) and biomarkers of effect and susceptibility.  This 
work will provide a further understanding of human PAH metabolism in vivo, and will help 
to inform dose-response relationships. 
The relationship between low to moderate levels of PAH exposure (specifically those 
from diesel exhaust and asphalt sources) and cancer risk is uncertain due to a general lack of 
quantitative exposure data.  In future occupational and environmental studies, air 
measurements of Nap and Phe should be considered as surrogates for total PAH exposure 
through airborne routes.  Measurements of Nap and Phe in air can be obtained using 
inexpensive passive techniques, allowing for more measurements at a given cost.  
Additionally, levels of Nap and Phe in urine, whether unmetabolized or as phenolic 
metabolites, should be considered as measurements of internal dose through multiple 
exposure routes.  These measurements of Nap and Phe in air and urine can be used to better 
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 understand the cancer risk associated with low to moderate levels of PAH exposure.  
However, future studies should closely consider the effects of PAH exposure through dermal 
and ingestion routes.  In our analysis, we considered dermal patch measurements of 
particulate PAHs.  Little work has been done to validate this technique as being suitable for 
the assessment of dermal PAH exposure.  Future work should evaluate the suitability of this 
method, specifically addressing the dermal absorption kinetics of particle-bound PAHs.  
Accurate data representing PAH exposure through inhalation, dermal, and ingestion routes 
are needed to better understand the contribution to total dose from each pathway.  This 
information will ultimately aid in establishing links between exposure, internal dose, and 
health effects. 
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